Shuo Ma, Ph.D. - Publications

Affiliations: 
2006 University of California, Santa Barbara, Santa Barbara, CA, United States 
Area:
Geophysics

24/382 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Harris RA, Barall M, Aagaard B, Ma S, Roten D, Olsen K, Duan B, Liu D, Luo B, Bai K, Ampuero J, Kaneko Y, Gabriel A, Duru K, Ulrich T, et al. A Suite of Exercises for Verifying Dynamic Earthquake Rupture Codes Seismological Research Letters. 89: 1146-1162. DOI: 10.1785/0220170222  0.517
2018 Hirakawa E, Ma S. Undrained Gouge Plasticity Stabilizes Rupture Dynamics of Rough FaultsUndrained Gouge Plasticity Stabilizes Rupture Dynamics of Rough Faults Bulletin of the Seismological Society of America. 108: 3160-3168. DOI: 10.1785/0120180002  0.468
2016 Andrews DJ, Ma S. Validating a dynamic earthquake model to produce realistic ground motion Bulletin of the Seismological Society of America. 106: 665-672. DOI: 10.1785/0120150251  0.513
2016 Hirakawa E, Ma S. Dynamic fault weakening and strengthening by gouge compaction and dilatancy in a fluid‐saturated fault zone Journal of Geophysical Research. 121: 5988-6008. DOI: 10.1002/2015Jb012509  0.564
2015 Ma S, Beroza GC. Ambient-field Green's functions from asynchronous seismic observations Geophysical Research Letters. 39. DOI: 10.1029/2011Gl050755  0.303
2013 Ma S, Hirakawa ET. Dynamic wedge failure reveals anomalous energy radiation of shallow subduction earthquakes Earth and Planetary Science Letters. 375: 113-122. DOI: 10.1016/J.Epsl.2013.05.016  0.579
2012 Ma S. A self-consistent mechanism for slow dynamic deformation and tsunami generation for earthquakes in the shallow subduction zone Geophysical Research Letters. 39. DOI: 10.1029/2012Gl051854  0.586
2011 Harris RA, Barall M, Andrews DJ, Duan B, Ma S, Dunham EM, Gabriel AA, Kaneko Y, Kase Y, Aagaard BT, Oglesby DD, Ampuero JP, Hanks TC, Abrahamson N. Verifying a computational method for predicting extreme ground motion Seismological Research Letters. 82: 638-644. DOI: 10.1785/Gssrl.82.5.638  0.446
2010 Aagaard BT, Graves RW, Rodgers A, Brocher TM, Simpson RW, Dreger D, Anders Petersson N, Larsen SC, Ma S, Jachens RC. Ground-motion modeling of hayward fault scenario earthquakes, part ii: Simulation of long-period and broadband ground motions Bulletin of the Seismological Society of America. 100: 2945-2977. DOI: 10.1785/0120090379  0.532
2010 Ma S, Andrews DJ. Inelastic off-fault response and three-dimensional dynamics of earthquake rupture on a strike-slip fault Journal of Geophysical Research. 115. DOI: 10.1029/2009Jb006382  0.58
2009 Harris RA, Barall M, Archuleta R, Dunham E, Aagaard B, Ampuero JP, Bhat H, Cruz-Atienza V, Dalguer L, Dawson P, Day S, Duan B, Ely G, Kaneko Y, Kase Y, ... ... Ma S, et al. The SCEC/USGS dynamic earthquake rupture code verification exercise Seismological Research Letters. 80: 119-126. DOI: 10.1785/Gssrl.80.1.119  0.708
2009 Ma S. Distinct asymmetry in rupture‐induced inelastic strain across dipping faults: An off‐fault yielding model Geophysical Research Letters. 36. DOI: 10.1029/2009Gl040666  0.591
2008 Ma S, Prieto GA, Beroza GC. Testing community velocity models for southern California using the ambient seismic field Bulletin of the Seismological Society of America. 98: 2694-2714. DOI: 10.1785/0120080947  0.351
2008 Ma S, Beroza GC. Rupture dynamics on a bimaterial interface for dipping faults Bulletin of the Seismological Society of America. 98: 1642-1658. DOI: 10.1785/0120070201  0.586
2008 Ma S. A physical model for widespread near‐surface and fault zone damage induced by earthquakes Geochemistry Geophysics Geosystems. 9. DOI: 10.1029/2008Gc002231  0.592
2008 Ma S, Custódio S, Archuleta RJ, Liu P. Dynamic modeling of the 2004 Mw 6.0 Parkfield, California, earthquake Journal of Geophysical Research: Solid Earth. 113. DOI: 10.1029/2007Jb005216  0.713
2008 Sleep NH, Ma S. Production of brief extreme ground acceleration pulses by nonlinear mechanisms in the shallow subsurface Geochemistry Geophysics Geosystems. 9. DOI: 10.1029/2007Gc001863  0.457
2007 O'Connell DRH, Ma S, Archuleta RJ. Influence of dip and velocity heterogeneity on reverse- and normal-faulting rupture dynamics and near-fault ground motions Bulletin of the Seismological Society of America. 97: 1970-1989. DOI: 10.1785/0120070042  0.719
2007 Ma S, Archuleta RJ, Page MT. Effects of large-scale surface topography on ground motions, as demonstrated by a study of the San Gabriel Mountains, Los Angeles, California Bulletin of the Seismological Society of America. 97: 2066-2079. DOI: 10.1785/0120070040  0.701
2006 Ma S, Liu P. Modeling of the Perfectly Matched Layer Absorbing Boundaries and Intrinsic Attenuation in Explicit Finite-Element Methods Bulletin of the Seismological Society of America. 96: 1779-1794. DOI: 10.1785/0120050219  0.301
2006 Ma S, Archuleta RJ. Radiated seismic energy based on dynamic rupture models of faulting Journal of Geophysical Research: Solid Earth. 111. DOI: 10.1029/2005Jb004055  0.712
2004 Ma S, Archuleta RJ, Liu P. Hybrid modeling of elastic P-SV wave motion: A combined finite-element and staggered-grid finite-difference approach Bulletin of the Seismological Society of America. 94: 1557-1563. DOI: 10.1785/012003087  0.636
2003 Zhang RR, Ma S, Hartzell S. Signatures of the Seismic Source in EMD-Based Characterization of the 1994 Northridge, California, Earthquake Recordings Bulletin of the Seismological Society of America. 93: 501-518. DOI: 10.1785/0120010285  0.436
2003 Zhang RR, Ma S, Safak E, Hartzell S. Hilbert-Huang transform analysis of dynamic and earthquake motion recordings Journal of Engineering Mechanics. 129: 861-875. DOI: 10.1061/(Asce)0733-9399(2003)129:8(861)  0.334
Low-probability matches (unlikely to be authored by this person)
2019 Nie S, Anthony D, Ma S. Testing the Amplitude of the Deconvolution‐Based Ambient Field Green's Functions by 3‐D Simulations of Elastic Wave Propagation in Sedimentary Basins Journal of Geophysical Research. 124: 7213-7226. DOI: 10.1029/2018Jb017197  0.29
2019 Ma S, Nie S. Dynamic Wedge Failure and Along‐Arc Variations of Tsunamigenesis in the Japan Trench Margin Geophysical Research Letters. 46: 8782-8790. DOI: 10.1029/2019Gl083148  0.279
1997 Ma SZ. A self-consistent normal stat istical model of geomagnetic field and its secular variation Acta Geophysica Sinica. 40.  0.149
2023 Ding N, Zhao Y, Wang W, Liu X, Shi W, Zhang D, Chen J, Ma S, Sun Q, Wang T, Lu M. Transcriptome analysis in contrasting maize inbred lines and functional analysis of five maize NAC genes under drought stress treatment. Frontiers in Plant Science. 13: 1097719. PMID 36743547 DOI: 10.3389/fpls.2022.1097719  0.137
1982 Ma SM. Research on the determination of whole process curve of rock's stress-strain using electro-hydraulic servo testing machine Journal of Hydraulic Engineering. 59-63.  0.134
1979 Ma SK. Alternative approach to the dynamic renormalization group Physical Review B. 19: 4824-4837. DOI: 10.1103/Physrevb.19.4824  0.13
1996 Ma S. A balancing technique to stabilize local torque optimization solution of redundant manipulators Journal of Robotic Systems. 13: 177-185.  0.128
1988 Ma SW. A central crack in a rectangular sheet where its boundary is subjected to an arbitrary anti-plane load Engineering Fracture Mechanics. 30: 435-443. DOI: 10.1016/0013-7944(88)90054-9  0.127
1988 Ma SW. A central crack normal to the interface between two different materials in a rectangular sheet under an anti-plane shear stress Engineering Fracture Mechanics. 30: 759-765. DOI: 10.1016/0013-7944(88)90137-3  0.124
1981 Ma Sk. Calculation of entropy from data of motion Journal of Statistical Physics. 26: 221-240. DOI: 10.1007/BF01013169  0.123
2024 Melody M, Epperla N, Shouse G, Romancik JT, Allen PB, Moyo TK, Kenkre VP, Ollila TA, Fitzgerald LA, Hess BT, David KA, Herr MM, Odetola O, Lin AY, Moreira J, ... Ma S, et al. Subsequent Malignant Neoplasms in Patients Previously Treated with Anti-CD19 CAR T-Cell Therapy. Blood Advances. PMID 38498727 DOI: 10.1182/bloodadvances.2024012573  0.12
2023 Ma S, Liu G, Peng P, Zhang B, Jandura S, Claes J, Burgers AP, Pupillo G, Puri S, Thompson JD. High-fidelity gates and mid-circuit erasure conversion in an atomic qubit. Nature. 622: 279-284. PMID 37821593 DOI: 10.1038/s41586-023-06438-1  0.118
1997 Ma SZ. On the angular dispersion of VGP and the lower degree components of the geomagnetic field Acta Geophysica Sinica. 40: 179-180.  0.11
1999 Ma SZ. A statistical spherical isotropic model of magnetized lithosphere Acta Geophysica Sinica. 42: 102-111.  0.109
1999 Ma SZ. The spectral theoty of electric and magnetic fields in a three dimensional inhomogeneous mantle (II) - A perturbation of gradually lateral variation and rapid diffusion of poloidal field Acta Geophysica Sinica. 42: 322-332.  0.104
1983 Ma SY. BOUNDARY ELEMENTS APPLIED TO STEADY HEAT CONDUCTION PROBLEMS . 76-87.  0.103
2012 Ma SM. Asian diaspora and east-west modernity Asian Diaspora and East-West Modernity. 1-168.  0.102
1972 Ma SK. Transverse waves in a weakly interacting bose gas Physical Review A. 5: 2632-2642. DOI: 10.1103/Physreva.5.2632  0.1
1999 Ma SY. The rise and fall of Bureaucratic-Authoritarianism in Chile Studies in Comparative International Development. 34: 51-65.  0.098
2023 Huang S, Zhang L, Luo J, Wu D, Ma K, Chen Y, Ma S, Feng L, Li F, Liu D, Deng J, Tan C. Cysteamine and -Acetyl-cysteine Alleviate Placental Oxidative Stress and Barrier Function Damage Induced by Deoxynivalenol. Journal of Agricultural and Food Chemistry. 71: 6846-6858. PMID 37122089 DOI: 10.1021/acs.jafc.3c00399  0.096
1945 Ma ST. Fourier transforms of retarded and advanced potentials Physical Review. 68: 166-172. DOI: 10.1103/PhysRev.68.166  0.096
1976 Ma SK. Renormalization group by monte carlo methods Physical Review Letters. 37: 461-464. DOI: 10.1103/PhysRevLett.37.461  0.094
2022 Ma S, Guo J, Zeng S, Che H, Pan X. Modeling eye movement in dynamic interactive tasks for maximizing situation awareness based on Markov decision process. Scientific Reports. 12: 13298. PMID 35918377 DOI: 10.1038/s41598-022-17433-3  0.093
1995 Ma S. Automatically modeling, simulating and explaining physical systems Computers and Industrial Engineering. 29: 187-191. DOI: 10.1016/0360-8352(95)00069-D  0.092
2010 Ma S. Seasonal simulation of ozone by air quality model-CMAQ in the great lakes 2010 4th International Conference On Bioinformatics and Biomedical Engineering, Icbbe 2010. DOI: 10.1109/ICBBE.2010.5516066  0.091
1987 Ma S. Theoretical analysis and calculation of fabric pre-shrinkage by rubber-blanket-type shrinkage machine 0.09
2001 Ma S. Power out of control and characteristics of a pump system Nongye Jixie Xuebao/Transactions of the Chinese Society of Agricultural Machinery. 32: 51-54.  0.09
1991 Ma SY. A boundary element solution to transient heat transfer problems of thin plates Engineering Analysis With Boundary Elements. 8: 155-163. DOI: 10.1016/0955-7997(91)90025-O  0.087
2001 Ma S. Analysis of creeping locomotion of a snake-like robot Advanced Robotics. 15: 205-224. DOI: 10.1163/15685530152116236  0.087
1997 Ma SZ. Spherical isotropic stochastic vector fields in geomagnetism Acta Geophysica Sinica. 40: 36-37.  0.086
2023 Shi D, Ma S, Zhang Q. Sliding mode dynamics and optimal control for HIV model. Mathematical Biosciences and Engineering : Mbe. 20: 7273-7297. PMID 37161151 DOI: 10.3934/mbe.2023315  0.086
1958 Ma ST. The casual function and the causality condition Nuclear Physics. 7: 163-168.  0.086
1947 Ma ST. Equivalence of the Riesz method and the -limiting process for the classical electromagnetic field of a point source Physical Review. 71: 787-792. DOI: 10.1103/PhysRev.71.787  0.084
1999 Ma S. STEP standard's evaluation for modeling in electromagnetism Compel - the International Journal For Computation and Mathematics in Electrical and Electronic Engineering. 18: 311-322.  0.082
2020 Ma S, Chan RJ, Gu L, Xing G, Rajakumaraswamy N, Ruzicka BB, Wagner-Johnston ND. Retrospective Analysis of the Impact of Adverse Event-Triggered Idelalisib Interruption and Dose Reduction on Clinical Outcomes in Patients With Relapsed/Refractory B-Cell Malignancies. Clinical Lymphoma, Myeloma & Leukemia. PMID 33516721 DOI: 10.1016/j.clml.2020.12.016  0.082
2017 Noy A, de Vos S, Thieblemont C, Martin P, Flowers CR, Morschhauser F, Collins GP, Ma S, Coleman M, Peles S, Smith S, Barrientos JC, Smith A, Munneke B, Dimery I, et al. Targeting BTK with ibrutinib in relapsed/refractory marginal zone lymphoma. Blood. PMID 28167659 DOI: 10.1182/blood-2016-10-747345  0.082
1940 Ma ST. Deviation from the Coulomb law for the proton Mathematical Proceedings of the Cambridge Philosophical Society. 36: 441-445. DOI: 10.1017/S0305004100017485  0.08
1946 Ma ST. Redundant zeros in the discrete energy spectra in heisenberg's theory of characteristic matrix [4] Physical Review. 69: 668. DOI: 10.1103/PhysRev.69.668  0.079
2021 Lu P, Wang S, Franzen CA, Venkataraman G, McClure R, Li L, Wu W, Niu N, Sukhanova M, Pei J, Baldwin DA, Nejati R, Wasik MA, Khan N, Tu Y, ... ... Ma S, et al. Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer Journal. 11: 39. PMID 33602908 DOI: 10.1038/s41408-021-00429-z  0.078
1974 Ma SK. Scaling variables and dimensions Physical Review A. 10: 1818-1836. DOI: 10.1103/PhysRevA.10.1818  0.076
1988 Ma SW. A central crack in a finite rectangular plate with constrained edges parallel to the crack under the opening mode Engineering Fracture Mechanics. 31: 493-500. DOI: 10.1016/0013-7944(88)90091-4  0.076
2019 Roberts AW, Ma S, Kipps TJ, Coutre SE, Davids MS, Eichhorst B, Hallek M, Byrd JC, Humphrey K, Zhou L, Chyla B, Nielsen J, Potluri J, Kim SY, Verdugo M, et al. Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables. Blood. PMID 31023700 DOI: 10.1182/blood.2018882555  0.076
2020 Pearse WB, Vakkalagadda CV, Helenowski I, Winter JN, Gordon LI, Karmali R, Ma S, Leventhal JR, Friedewald J, Ganger D, Pro B. Prognosis and Outcomes of Patients with Post-Transplant Lymphoproliferative Disorder: A Single Center Retrospective Review Blood. 136: 9-10. DOI: 10.1182/blood-2020-141286  0.075
2021 Ma S, Ma Y, Zhang B, Tian Y, Jin Z. Forecasting System of Computational Time of DFT/TDDFT Calculations under the Multiverse Ansatz via Machine Learning and Cheminformatics. Acs Omega. 6: 2001-2024. PMID 33521440 DOI: 10.1021/acsomega.0c04981  0.075
2019 Karmali R, Abramson JS, Stephens DM, Barnes JA, Kaplan J, Winter JN, Ma S, Gao J, Petrich AM, Hochberg E, Takvorian RW, Kuhr F, Nelson V, Gordon LI, Pro B. Ibrutinib Maintenance (I-M) Following Frontline Intensive Induction in Mantle Cell Lymphoma (MCL): Interim Safety, Response and Sequential MRD Evaluation Blood. 134: 3990-3990. DOI: 10.1182/Blood-2019-126920  0.075
1996 Ma SL. Regular automorphism groups on partial geometries Journal of Statistical Planning and Inference. 51: 215-222. DOI: 10.1016/0378-3758(95)00086-0  0.075
1984 Ma SL. A Note on Binary Arrays with a Certain Window Property Ieee Transactions On Information Theory. 30: 774-775. DOI: 10.1109/TIT.1984.1056947  0.073
1980 Ma SP. An epidemiologic investigation of psychoses in Laoshan County of Qingdao (author's transl) Chinese Journal of Neurology and Psychiatry. 13: 22-23. PMID 7428534  0.072
2020 Trotman J, Buske C, Tedeschi A, Matous JV, MacDonald D, Tam C, Tournilhac O, Ma S, Treon SP, Oriol A, Ping J, Briso EM, Arango-Hisijara I, Dimopoulos MA. Long-Term Follow-up of Ibrutinib Treatment for Rituximab-Refractory Waldenström's Macroglobulinemia: Final Analysis of the Open-Label Substudy of the Phase 3 iNNOVATETM Trial Blood. 136: 38-39. DOI: 10.1182/BLOOD-2020-133916  0.071
1983 Ma SY. BOUNDARY ELEMENTS APPLIED TO ELASTOSTATICS . 1027-1035.  0.071
1980 Ma SK. Dynamics of a vector spin-glass model Physical Review B. 22: 4484-4502. DOI: 10.1103/Physrevb.22.4484  0.071
2023 Karmali R, Abramson JS, Stephens DM, Barnes JA, Winter JN, Ma S, Gao J, Kaplan J, Petrich AM, Mi X, Hochberg EP, Takvorian RW, Nelson V, Gordon LI, Pro B. Ibrutinib Maintenance Following Frontline Treatment in Patients with Mantle Cell Lymphoma. Blood Advances. PMID 37756532 DOI: 10.1182/bloodadvances.2023011271  0.07
2022 Strati P, Coleman M, Champion R, Ma S, Patti C, Levy MY, Lossos IS, Geethakumari PR, Lam S, Calvo R, Higgins K, Budde LE. A phase 2, multicentre, open-label trial (ACE-LY-003) of acalabrutinib in patients with relapsed or refractory marginal zone lymphoma. British Journal of Haematology. PMID 35861370 DOI: 10.1111/bjh.18368  0.07
2013 Tian H, Ma S, Zhao HM, Wu C, Ge J, Xie D, Yang Y, Ren TL. Flexible electrostatic nanogenerator using graphene oxide film. Nanoscale. 5: 8951-7. PMID 23963301 DOI: 10.1039/c3nr01658g  0.069
2018 Brander DM, Seymour JF, Ma S, Anderson MA, Choi MY, Kipps TJ, Humphrey K, Masud A, Nandam R, Kim SY, Verdugo ME, Roberts AW. Durability of Responses on Continuous Therapy and Following Drug Cessation in Deep Responders with Venetoclax and Rituximab Blood. 132: 183-183. DOI: 10.1182/BLOOD-2018-183  0.069
2013 Ma S. Correction to [Statist. Med., 32, (2013), 3594] Statistics in Medicine. 32: 3594-3594. DOI: 10.1002/sim.5860  0.069
2018 Brown JR, Davids MS, Chang J, Ma S, Biondo J, Mobasher M, Mun Y, Mato AR. Outcomes of Ibrutinib Therapy Given after Prior Venetoclax Therapy in Ibrutinib-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Blood. 132: 5556-5556. DOI: 10.1182/BLOOD-2018-99-116942  0.069
2020 Karmali R, Abramson JS, Stephens DM, Barnes JA, Kaplan J, Winter JN, Ma S, Gao J, Petrich AM, Hochberg E, Takvorian R, Kuhr F, Nelson V, Gordon LI, Pro B. Ibrutinib Maintenance (I-M) Following Intensive Induction in Mantle Cell Lymphoma (MCL): Efficacy, Safety and Changes in Minimal Residual Disease Blood. 136: 30-31. DOI: 10.1182/BLOOD-2020-137695  0.068
2015 Ma S, Brander DM, Seymour JF, Kipps TJ, Barrientos JC, Davids MS, Anderson MA, Choi MY, Tam CS, Mason-Bright T, Prine B, Munasinghe W, Zhu M, Kim SY, Humerickhouse RA, et al. Deep and Durable Responses Following Venetoclax (ABT-199 / GDC-0199) Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Results from a Phase 1b Study Blood. 126: 830-830. DOI: 10.1182/BLOOD.V126.23.830.830  0.068
2020 Mato AR, Roeker LE, Lamanna N, Allan J, Leslie LA, Pagel JM, Patel K, Osterborg A, Wojenski D, Kamdar M, Huntington SF, Davids MS, Brown JR, Antic D, Jacobs RW, ... ... Ma S, et al. Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience. Blood. PMID 32688395 DOI: 10.1182/blood.2020006965  0.068
1996 Ma S. A unified framework for modeling, simulating and explaining engineering systems Computers and Industrial Engineering. 31: 839-842.  0.068
2020 Noy A, de Vos S, Coleman M, Martin P, Flowers CR, Thieblemont C, Morschhauser F, Collins GP, Ma S, Peles S, Smith SD, Barrientos JC, Chong E, Wu S, Cheung LW, et al. Durable ibrutinib responses in relapsed/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis. Blood Advances. 4: 5773-5784. PMID 33227125 DOI: 10.1182/bloodadvances.2020003121  0.067
2013 Brown JR, Harb WA, Hill BT, Gabrilove J, Sharman JP, Schreeder MT, Barr PM, Foran JM, Miller TP, Burger JA, Kelly KR, Mahadevan D, Ma S, Barnett E, Marine J, et al. Phase 1 Study Of Single Agent CC-292, a Highly Selective Bruton's Tyrosine Kinase (BTK) Inhibitor, In Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Blood. 122: 1630-1630. DOI: 10.1182/Blood.V122.21.1630.1630  0.067
2023 Hill BT, Ma S, Zent CS, Baran AM, Wallace DS, Advani AS, Winter AM, Winter JN, Gordon LI, Karmali R, Liesveld JL, Mulford DA, Rowland C, Bui A, Sportelli P, et al. Response-Adapted, Time-Limited Venetoclax, Umbralisib and Ublituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia. Blood Advances. PMID 37871300 DOI: 10.1182/bloodadvances.2023010693  0.067
2019 Ma S, Chan RJ, Gu L, Xing G, Rajakumaraswamy N, Ruzicka B, Wagner-Johnston ND. Impact of Idelalisib Treatment Interruption with or without Dose Reduction on Outcomes in Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia Blood. 134: 5468-5468. DOI: 10.1182/Blood-2019-124541  0.067
1989 Ma SW. A central crack of mode III in a rectangular sheet with fixed edges International Journal of Fracture. 39: 323-329. DOI: 10.1007/BF00017704  0.067
2015 Ma S. Fuzzy comprehensive evaluation method-based big data era Chinese sports brands independent innovation ability research Open Cybernetics and Systemics Journal. 9: 2290-2294.  0.067
1952 Ma ST. Bound states and the interaction representation Physical Review. 87: 652-655. DOI: 10.1103/PhysRev.87.652  0.066
2021 Tao M, Zheng M, Xu Y, Ma S, Zhang W, Ju S. CircRNAs and their regulatory roles in cancers. Molecular Medicine (Cambridge, Mass.). 27: 94. PMID 34445958 DOI: 10.1186/s10020-021-00359-3  0.065
2014 Gandhi M, Ma S, Smith SM, Nabhan C, Evens AM, Winter JN, Gordon LI, Petrich AM. Brentuximab Vedotin (BV) Plus Rituximab (R) As Frontline Therapy for Patients (Pts) with Epstein Barr Virus (EBV)+ and/or CD30+ Lymphoma: Phase I Results of an Ongoing Phase I-II Study Blood. 124: 3096-3096. DOI: 10.1182/BLOOD.V124.21.3096.3096  0.065
2007 Ma SM. East-West Montage: Reflections on asian bodies in diaspora East-West Montage: Reflections On Asian Bodies in Diaspora. 1-302.  0.065
2023 Xu W, Zhou K, Wang T, Yang S, Liu L, Hu Y, Zhang W, Ding K, Zhou J, Gao S, Xu B, Zhu Z, Liu T, Zhang H, Hu J, ... ... Ma S, et al. Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. American Journal of Hematology. PMID 36683422 DOI: 10.1002/ajh.26826  0.065
2003 Ma S. Conformal and Lie superalgebras motivated from free fermionic fields Journal of Physics a: Mathematical and General. 36: 1759-1787. DOI: 10.1088/0305-4470/36/6/318  0.065
1972 Ma SK. Critical exponents for charged and neutral bose gases above points Physical Review Letters. 29: 1311-1314. DOI: 10.1103/PhysRevLett.29.1311  0.064
1999 Ma S. Comparisons of the parallel preconditioners on the cray-T3E for large nonsymmetric linear systems International Journal of High Speed Computing. 10: 285-300.  0.064
2016 Noy A, de Vos S, Thieblemont C, Martin P, Flowers C, Morschhauser F, Collins GP, Ma S, Coleman M, Peles S, Smith S, Smith A, Munneke B, Dimery I, Beaupre D, et al. Single-Agent Ibrutinib Demonstrates Efficacy and Safety in Patients with Relapsed/Refractory Marginal Zone Lymphoma: A Multicenter, Open-Label, Phase 2 Study Blood. 128: 1213-1213. DOI: 10.1182/BLOOD.V128.22.1213.1213  0.064
2021 Ma S, Seymour JF, Brander DM, Kipps TJ, Choi MY, Anderson MA, Humphrey K, Al Masud A, Pesko J, Nandam R, Salem AH, Chyla B, Arzt J, Jacobson A, Kim SY, et al. Efficacy of venetoclax plus rituximab for relapsed CLL: Five-year follow-up of continuous or limited-duration therapy. Blood. PMID 34115103 DOI: 10.1182/blood.2020009578  0.064
2020 Yang J, Cui D, Ma S, Chen W, Chen D, Shen H. Characterization of a novel PL 17 family alginate lyase with exolytic and endolytic cleavage activity from marine bacterium Microbulbifer sp. SH-1. International Journal of Biological Macromolecules. PMID 33385459 DOI: 10.1016/j.ijbiomac.2020.12.196  0.063
2020 Galvez C, Karmali R, Hamadani M, Gordon LI, Winter JN, Ma S, Nelson V, Palmer BA, Fenske TS, Shah NN, Jagadeesh D, Klein A, Helenowski I, Jovanovic B, Petrich AM, et al. A Phase I-II Trial of DA-EPOCH-R Plus Ixazomib As Frontline Therapy for Patients with MYC-Aberrant Lymphoid Malignancies: The Daciphor Regimen Blood. 136: 44-45. DOI: 10.1182/blood-2020-138532  0.063
2001 Ma S. Kinematic/static dexterity measure of manipulators with limit-driven characteristics of actuators Proceedings - Ieee International Conference On Robotics and Automation. 4: 4035-4040.  0.063
2023 Zou M, Zhou M, Ma S, Zhang C, Xiao F, Wu H, GuliNaizhaer A, Yao Y, Chen Y, Cai S, Fan X, Zhao F, Wu G. Addition of dNTPs can improve the detection sensitivity of catalytic hairpin assembly. Iscience. 26: 106390. PMID 37034995 DOI: 10.1016/j.isci.2023.106390  0.063
2000 Ma SY. Understanding China's reform: Looking beyond neoclassical explanations World Politics. 52: 586-603.  0.063
2021 Zhang DY, Ma SS, Sun WL, Lv XCH, Lu Z. KIF4A as a novel prognostic biomarker in cholangiocarcinoma. Medicine. 100: e26130. PMID 34032761 DOI: 10.1097/MD.0000000000026130  0.062
1971 Ma SK. Second sound in a low-temperature weakly interacting Bose gas Journal of Mathematical Physics. 12: 2157-2170.  0.062
1994 Ma SL. A survey of partial difference sets Designs, Codes and Cryptography. 4: 221-261. DOI: 10.1007/BF01388454  0.062
1983 Ma S. Objective basis of the common law of population Population Research (Peking, China). 1: 9-14. PMID 12313979  0.062
2023 Dou Y, Zhang Y, Zhang S, Ma S, Zhang H. Multi-functional conductive hydrogels based on heparin-polydopamine complex reduced graphene oxide for epidermal sensing and chronic wound healing. Journal of Nanobiotechnology. 21: 343. PMID 37741961 DOI: 10.1186/s12951-023-02113-9  0.062
2021 Trotman J, Buske C, Tedeschi A, Matous JV, MacDonald D, Tam CS, Tournilhac O, Ma S, Treon SP, Oriol A, Ping J, Briso de Montiano EM, Arango-Hisijara I, Dimopoulos MA. Single-Agent Ibrutinib for Rituximab-Refractory Waldenström's Macroglobulinemia: Final Analysis of the Substudy of the Phase III iNNOVATE Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34380643 DOI: 10.1158/1078-0432.CCR-21-1497  0.061
1973 Ma SK. Introduction to the Renormalization Group Reviews of Modern Physics. 45: 589-614. DOI: 10.1103/RevModPhys.45.589  0.06
2019 Ma S, Zhang C, Yuan TF, Steele D, Voon V, Sun B. Neurosurgical treatment for addiction: lessons from an untold story in China and a path forward. National Science Review. 7: 702-712. PMID 34692088 DOI: 10.1093/nsr/nwz207  0.06
1973 Ma S. Renormalization group in the large N limit Physics Letters A. 43: 475-476. DOI: 10.1016/0375-9601(73)90428-3  0.06
2014 Holkova B, Kmieciak M, Bose P, Ma S, Kimball A, Tombes MB, Shrader E, Wan W, Weir-Wiggins C, Stoddert E, Singh AG, Dean A, Conine S, Sankala H, Roberts JD, et al. Phase 1 Study of Bortezomib and Romidepsin in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Indolent B-Cell Lymphoma, Peripheral T-Cell Lymphoma, or Cutaneous T-Cell Lymphoma: Updated Results Blood. 124: 3050-3050. DOI: 10.1182/Blood.V124.21.3050.3050  0.06
2017 Collins G, Noy A, de Vos S, Thieblemont C, Martin P, Flowers C, Morschhauser F, Ma S, Coleman M, Peles S, Smith S, Barrientos J, Smith A, Munneke B, Dimery I, et al. Safety and efficacy of single-agent ibrutinib in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL): A multicenter, open-label, phase 2 study Hematological Oncology. 35: 211-212. DOI: 10.1002/hon.2438_76  0.06
1942 Ma ST. Calculations of the ccattering of mesons by the matrix method Physical Review. 62: 403-411. DOI: 10.1103/PhysRev.62.403  0.059
2018 Ma SN, Wang HJ, Wang HZ, Li Y, Liu M, Liang XM, Yu Q, Jeppesen E, Søndergaard M. High ammonium loading can increase alkaline phosphatase activity and promote sediment phosphorus release: A two-month mesocosm experiment. Water Research. 145: 388-397. PMID 30173099 DOI: 10.1016/j.watres.2018.08.043  0.059
2008 Ma S, Zhan F, Ma C, Tessel M, Zhang L, Rajkumar SV, Singhal S, Barlogie B, Shaughnessy J, Rosen ST, Krett N. Glucocorticoid Receptor Expression Correlates with Clinical Outcome in Myeloma Patients Treated with Glucocorticoid-Containing Regimens. Blood. 112: 1700-1700. DOI: 10.1182/blood.v112.11.1700.1700  0.059
2001 Ma SD. The properties of stabilized light soil (SLS) with expanded polystyrene Rock and Soil Mechanics. 22: 245-248+314.  0.059
2019 Wang YLL, Franzen C, Wang S, Venkataraman G, Li L, Niu N, Sukhanova M, Tu Y, Gao J, Chen Y, Ma S, Larson RA, Pin L. Ibrutinib and Venetoclax Target Distinct Subpopulation of CLL Cells: Rationale for Drug Combination and Implication of Minimal Residual Disease Eradication Blood. 134: 475-475. DOI: 10.1182/blood-2019-125396  0.058
1956 Ma ST. Contact and core interactions according to Dirac's relativistic theory of the electron Nuclear Physics. 2: 347-355.  0.058
2023 Ma S, Yao Y, Xu Y, Zou M, Zhou M, Abudushalamu G, Chen Y, Cai S, Zhang C, Wu G. Comprehensive evaluation of serum circHAS2 as a novel diagnostic and prognostic biomarker for gastric cancer. Molecular Carcinogenesis. PMID 37750590 DOI: 10.1002/mc.23638  0.058
2003 Ma SD. Stability and settlement of embankment filled with stabilized light soil Yantu Lixue/Rock and Soil Mechanics. 24: 331-334.  0.058
2022 Karmali R, St-Pierre F, Ma S, Foster KD, Kaplan J, Mi X, Pro B, Winter JN, Gordon LI. Phase I study of novel SYK inhibitor TAK-659 (mivavotinib) in combination with R-CHOP for front-line treatment of high-risk diffuse large B-cell lymphoma. Ejhaem. 4: 108-114. PMID 36819145 DOI: 10.1002/jha2.625  0.058
2014 Roberts AW, Ma S, Brander DM, Kipps TJ, Barrientos JC, Davids MS, Anderson MA, Tam C, Mason-Bright T, Rudersdorf NK, Gressick L, Yang J, Munasinghe W, Zhu M, Cerri E, et al. Determination of Recommended Phase 2 Dose of ABT-199 (GDC-0199) Combined with Rituximab (R) in Patients with Relapsed / Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) Blood. 124: 325-325. DOI: 10.1182/BLOOD.V124.21.325.325  0.057
2012 Brown JR, Sharman JP, Harb WA, Kelly KR, Schreeder MT, Sweetenham JW, Barr PM, Foran JM, Gabrilove JL, Kipps TJ, Ma S, O'Brien SM, Evans E, Lounsbury H, Silver BA, et al. Phase Ib trial of AVL-292, a covalent inhibitor of Bruton's tyrosine kinase (Btk), in chronic lymphocytic leukemia (CLL) and B-non-Hodgkin lymphoma (B-NHL). Journal of Clinical Oncology. 30: 8032-8032. DOI: 10.1200/JCO.2012.30.15_SUPPL.8032  0.057
2021 Gu X, Ma S, Liang B, Ju S. Serum hsa_tsr016141 as a Kind of tRNA-Derived Fragments Is a Novel Biomarker in Gastric Cancer Frontiers in Oncology. 11. DOI: 10.3389/fonc.2021.679366  0.057
2019 Pearse W, Pro B, Gordon LI, Karmali R, Winter JN, Ma S, Behdad A, Klein A, Petrich AM, Jovanovic B, Smith SM, Evans AG. A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) As Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas Blood. 134: 351-351. DOI: 10.1182/blood-2019-127390  0.057
1987 Ma SM. Contrasting two survival literatures: On the jewish holocaust and the Chinese cultural revolution Holocaust and Genocide Studies. 2: 81-93. DOI: 10.1093/hgs/2.1.81  0.056
2018 Ma S, Chan RJ, Ye W, Xing G, Brubaker CE, Roudet C, Ruzicka B, Wagner-Johnston ND. Survival Outcomes Following Idelalisib Interruption in the Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia Blood. 132: 3149-3149. DOI: 10.1016/J.Clml.2019.07.284  0.056
2004 Liu Y, Shaw SK, Ma S, Yang L, Luscinskas FW, Parkos CA. Regulation of leukocyte transmigration: cell surface interactions and signaling events. Journal of Immunology (Baltimore, Md. : 1950). 172: 7-13. PMID 14688302 DOI: 10.4049/Jimmunol.172.1.7  0.056
2018 Pu Z, Ma S, Wang L, Li M, Shang L, Luo Y, Chen W. Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans model of Alzheimer's disease. Neuroscience. PMID 30267833 DOI: 10.1016/j.neuroscience.2018.09.022  0.056
2008 Ma SC. A new super-orthogonal space-time block code 2008 Ieee Radio and Wireless Symposium, Rws. 567-570. DOI: 10.1109/RWS.2008.4463555  0.056
1999 Ma SK. Man of efficiency and man of ethics: Can China's administrative reform produce both for her economic development? Policy Studies Review. 16: 133-146.  0.055
2010 Ma SJ. Resolution of the unity of normally ordered gaussian operator form for constructing new quantum mechanical representations Modern Physics Letters B. 24: 81-87. DOI: 10.1142/S0217984910022159  0.055
2023 Ma S, Zhao B, Deng J. Helical Polymer Working as a Chirality Amplifier to Generate and Modulate Multicolor Circularly Polarized Luminescence in Small Molecular Fluorophore/Polymer Composite Films. Acs Central Science. 9: 1409-1418. PMID 37521789 DOI: 10.1021/acscentsci.3c00122  0.055
2002 Ma S. Time-optimal control of robotic manipulators with limit heat characteristics of the actuator Advanced Robotics. 16: 309-324. DOI: 10.1163/15685530260174502  0.055
2023 Ma S, Chen T, Jia W, Liu J, Ding S, Li P, Gan H, Zhang D, Shao S, Poo MM, Zhao M, Sun B, Jiang J. Enhanced Beta2-band Oscillations Denote Auditory Hallucination in Schizophrenia Patients and a Monkey Model of Psychosis. Neuroscience Bulletin. PMID 37612582 DOI: 10.1007/s12264-023-01100-2  0.055
2016 Brander DM, Choi MY, Roberts AW, Ma S, Lash LL, Verdugo M, Zhu M, Kim SY, Seymour JF. Detailed Safety Analysis of Venetoclax Combined with Rituximab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Blood. 128: 2033-2033. DOI: 10.1182/blood.v128.22.2033.2033  0.055
2002 Ma SJ. Numerical calculation of electric field and density cavitons in the vicinity of moving body Yuhang Xuebao/Journal of Astronautics. 23: 69.  0.055
2022 Qin S, Zhang Q, Xu Y, Ma S, Wang T, Huang Y, Ju S. mA-modified circRNAs: detections, mechanisms, and prospects in cancers. Molecular Medicine (Cambridge, Mass.). 28: 79. PMID 35836125 DOI: 10.1186/s10020-022-00505-5  0.054
2021 Pearse WB, Petrich AM, Gordon LI, Karmali R, Winter JN, Ma S, Kaplan JB, Behdad A, Klein A, Jovanovic B, Helenowski I, Smith SM, Evens AM, Pro B. A phase I/II trial of brentuximab vedotin plus rituximab as frontline therapy for patients with immunosuppression-associated CD30+ and/or EBV + lymphomas. Leukemia & Lymphoma. 1-8. PMID 34338127 DOI: 10.1080/10428194.2021.1957867  0.054
2014 Ma S, Rosen ST, Frankfurt O, Winter JN, Kreutzer J, Husa S, Österborg A, Lundin J. a Phase 2 Study of Alemtuzumab-Ofatumumab (A+O) Combination in Patients with Previously Untreated Chronic Lymphocytic Leukemia (CLL) Blood. 124: 4686-4686. DOI: 10.1182/BLOOD.V124.21.4686.4686  0.054
2021 Wei X, Huang M, Yue Q, Ma S, Li B, Mu Z, Peng C, Gao W, Liu W, Zheng J, Weng X, Sun X, Zuo Q, Bo S, Yuan X, et al. Long-term urbanization impacts the eastern golden frog () in Shanghai City: Demographic history, genetic structure, and implications for amphibian conservation in intensively urbanizing environments. Evolutionary Applications. 14: 117-135. PMID 33519960 DOI: 10.1111/eva.13156  0.054
2015 Dimopoulos MA, Trotman J, Tedeschi A, Matous JV, Macdonald D, Tam C, Tournilhac O, Ma S, Oriol A, Heffner LT, Shustik C, García-Sanz R, Cornell RF, Fernández de Larrea C, Castillo JJ, et al. Ibrutinib Therapy in Rituximab-Refractory Patients with Waldenström's Macroglobulinemia: Initial Results from an International, Multicenter, Open-Label Phase 3 Substudy (iNNOVATETM) Blood. 126: 2745-2745. DOI: 10.1182/BLOOD.V126.23.2745.2745  0.054
2015 Guo Y, Ma S, Guan S, Zhang Y, Pan J. High-Throughput Determination of Octanol-Water Partition Coefficients by Ultrasound-Assisted Liquid-Phase Microextraction. Journal of Chromatographic Science. PMID 25583971 DOI: 10.1093/chromsci/bmu218  0.054
2023 Chen C, Zhang J, Liu J, Li J, Ma S, Yu A. Sea Urchin-like NiCoO Catalyst Activated Peroxymonosulfate for Degradation of Phenol: Performance and Mechanism. Molecules (Basel, Switzerland). 29. PMID 38202736 DOI: 10.3390/molecules29010152  0.054
2016 Dimopoulos MA, Trotman J, Tedeschi A, Matous JV, Macdonald D, Tam C, Tournilhac O, Ma S, Oriol A, Heffner LT, Shustik C, García-Sanz R, Cornell RF, de Larrea CF, Castillo JJ, et al. Ibrutinib for patients with rituximab-refractory Waldenström's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial. The Lancet. Oncology. PMID 27956157 DOI: 10.1016/S1470-2045(16)30632-5  0.054
2023 Wu D, Xiong W, Ma S, Luo J, Ye H, Huang S, Li F, Xiang X, Chen Q, Gao B, Deng J, Yin Y, Tan C. Konjac flour-mediated gut microbiota alleviates insulin resistance and improves placental angiogenesis of obese sows. Amb Express. 13: 143. PMID 38087159 DOI: 10.1186/s13568-023-01646-4  0.054
2017 Holkova B, Yazbeck V, Kmieciak M, Bose P, Ma S, Kimball A, Tombes MB, Shrader E, Wan W, Weir-Wiggins C, Singh A, Hogan KT, Conine S, Sankala H, Roberts JD, et al. A phase 1 study of bortezomib and romidepsin in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, indolent B-cell lymphoma, peripheral T-cell lymphoma, or cutaneous T-cell lymphoma. Leukemia & Lymphoma. 1-9. PMID 28103725 DOI: 10.1080/10428194.2016.1276287  0.053
2022 He X, Wang X, Fan G, Li F, Wu W, Wang Z, Fu M, Wei X, Ma S, Ma X. Metagenomic analysis of viromes in tissues of wild Qinghai vole from the eastern Tibetan Plateau. Scientific Reports. 12: 17239. PMID 36241909 DOI: 10.1038/s41598-022-22134-y  0.053
2019 Brander DM, Seymour JF, Kipps TJ, Ma S, Anderson MA, Choi MY, Humphrey K, Masud AA, Nandam R, Jacobson A, Roberts AW. Durability of Responses on Continuous Therapy and Following Drug Cessation with Venetoclax and Rituximab: Long-Term Follow-up Analysis of a Phase 1b Study in Patients with Relapsed CLL Blood. 134: 3036-3036. DOI: 10.1182/blood-2019-126508  0.053
1998 Ma SY. The Chinese route to privatization: the evolution of the shareholding system option Asian Survey. 38: 379-397.  0.053
2020 Galvez C, Nizamuddin I, Tuchman E, Doukas P, Reddy N, Altman JK, Winter JN, Gordon LI, Barth D, Hodgins N, Pro B, Ma S, Dinner S, Frankfurt O, Mehta J, et al. Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience Blood. 136: 14-16. DOI: 10.1182/blood-2020-139495  0.052
2023 Jiang W, Jia X, Xie N, Wen C, Ma S, Jiang G, Li X, Chi C, Zhang D, Liu W. Aquafeed fermentation improves dietary nutritional quality and benefits feeding behavior, meat flavor, and intestinal microbiota of Chinese mitten crab (). Animal Nutrition (Zhongguo Xu Mu Shou Yi Xue Hui). 14: 1-19. PMID 37808949 DOI: 10.1016/j.aninu.2023.04.002  0.052
1992 Ma S. Prevention of Enzymatic Darkening in Frozen Sweet Potatoes [Ipomoea batatas (L.) Lam.] by Water Blanching: Relationship among Darkening, Phenols, and Polyphenol Oxidase Activity Journal of Agricultural and Food Chemistry®. 40: 864-867.  0.051
2023 Wang ML, Jurczak W, Zinzani PL, Eyre TA, Cheah CY, Ujjani CS, Koh Y, Izutsu K, Gerson JN, Flinn I, Tessoulin B, Alencar AJ, Ma S, Lewis D, Lech-Maranda E, et al. Pirtobrutinib in Covalent BTK-Inhibitor Pre-treated Mantle Cell Lymphoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 101200JCO2300562. PMID 37192437 DOI: 10.1200/JCO.23.00562  0.051
2016 Tam C, Roberts AW, Ma S, Brander D, Kipps TJ, Barrientos JC, Davids MS, Anderson MA, Choi M, Lash L, Verdugo M, Kim SY, Zhu M, Seymour JF. Cross-Study Multivariable Analysis of the Impact of Adding Rituximab to Venetoclax on the Depth and Durability of Response in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Clinical Lymphoma Myeloma and Leukemia. 16: S51. DOI: 10.1016/J.CLML.2016.07.074  0.05
2017 Li X, Cao T, Ma S, Jing Z, Bi Y, Zhou J, Chen C, Yu D, Zhu L, Li S. Curcumin ameliorates cardiac dysfunction induced by mechanical trauma. European Journal of Pharmacology. PMID 28802718 DOI: 10.1016/j.ejphar.2017.07.048  0.05
2008 Frankfurt O, Hamilton E, Duffey S, Acharya S, Raji A, Ma S, Peterson L, Goolsby C, Rosen ST. Alemtuzumab and Rituximab Combination Therapy for Patients with Untreated CLL – a Phase II Trial. Blood. 112: 2098-2098. DOI: 10.1182/BLOOD.V112.11.2098.2098  0.05
2019 Brown JR, Davids MS, Chang JE, Ma S, Biondo JML, Mun Y, Breuleux M, Wierda WG. Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven) Blood. 134: 4320-4320. DOI: 10.1182/blood-2019-123665  0.05
2003 Ma SC. Adaptive trace deletion method Proceedings of the Ieee International Symposium On Consumer Electronics, Isce. 180-181.  0.05
2022 St-Pierre F, Ma S. Use of BTK Inhibitors in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Practical Guidance. Blood and Lymphatic Cancer : Targets and Therapy. 12: 81-98. PMID 35911566 DOI: 10.2147/BLCTT.S326627  0.049
2020 Yang J, Cui D, Chen D, Chen W, Ma S, Shen H. Purification and Characterization of a Novel Endolytic Alginate Lyase from sp. SH-1 and Its Agricultural Application. Marine Drugs. 18. PMID 32244418 DOI: 10.3390/md18040184  0.049
2019 Barr PM, Hill BT, Ma S, Baran AM, Bui A, Meacham PJ, Morrison A, Liesveld JL, Mulford DA, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, Zent CS. A Phase 1/2 Study of Umbralisib Ublituximab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Blood. 134: 360-360. DOI: 10.1182/BLOOD-2019-123404  0.049
2019 Karmali R, Abramson JS, Stephens DM, Barnes JA, Kaplan JB, Winter JN, Ma S, Petrich AM, Hochberg EP, Takvorian T, Nelson V, Gordon LI, Pro B. Ibrutinib maintenance following induction for untreated mantle cell lymphoma (MCL): Initial safety report. Journal of Clinical Oncology. 37: 7542-7542. DOI: 10.1200/Jco.2019.37.15_Suppl.7542  0.048
2004 Shaw SK, Ma S, Kim MB, Rao RM, Hartman CU, Froio RM, Yang L, Jones T, Liu Y, Nusrat A, Parkos CA, Luscinskas FW. Coordinated redistribution of leukocyte LFA-1 and endothelial cell ICAM-1 accompany neutrophil transmigration. The Journal of Experimental Medicine. 200: 1571-80. PMID 15611287 DOI: 10.1084/Jem.20040965  0.048
2023 Lin W, Zheng X, Ma S, Ji K, Wang C, Chen M. Quasi-Solid Polymer Electrolyte with Multiple Lithium-Ion Transport Pathways by In Situ Thermal-Initiating Polymerization. Acs Applied Materials & Interfaces. 15: 8128-8137. PMID 36744574 DOI: 10.1021/acsami.2c20884  0.048
2023 Gulinaizhaer A, Yang C, Zou M, Ma S, Fan X, Wu G. Detection of monkeypox virus using helicase dependent amplification and recombinase polymerase amplification combined with lateral flow test. Virology Journal. 20: 274. PMID 37996921 DOI: 10.1186/s12985-023-02223-8  0.048
2017 Regan JA, Cao Y, Dispenza MC, Ma S, Gordon LI, Petrich AM, Bochner BS. Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity. The Journal of Allergy and Clinical Immunology. PMID 28389390 DOI: 10.1016/J.Jaci.2017.03.013  0.048
2021 Handunnetti S, Anderson MA, Roberts AW, Davids MS, Ma S, Boyer M, Arzt J, Masud AA, Popovic R, Jacobson A, Kim SY, Seymour JF. Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy. Ejhaem. 2: 266-271. PMID 35845292 DOI: 10.1002/jha2.177  0.048
2017 Wang M, Yi Y, Cao J, Wang Y, Qi B, Ma S, Wang Y. Optimization of kV Selection on Third-generation High-pitch Dual-source Coronary CT Angiography Using Ultra-low Contrast Media Protocols in Patients with Body Mass Index between 20-30 kg/m(2) under Automatic Tube Voltage Selection. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 39: 49-55. PMID 28270283 DOI: 10.3881/j.issn.1000-503X.2017.01.009  0.048
2013 Ma S. The design of two pendulums spherical robot Applied Mechanics and Materials. 312: 741-744. DOI: 10.4028/www.scientific.net/AMM.312.741  0.048
2024 Karmali R, Galvez C, Hamadani M, Gordon LI, Winter JN, Ma S, Nelson V, Fenske TS, Shah NN, Jagadeesh D, Klein AK, Helenowski I, Chen R, Mi X, Petrich A, et al. A Phase I-II Trial of DA-EPOCH-R Plus Ixazomib for MYC-Aberrant Lymphoid Malignancies: The DACIPHOR Regimen. Blood Advances. PMID 38237077 DOI: 10.1182/bloodadvances.2023011369  0.048
2003 Ma SM. Rodgers and Hammerstein's "Chopsticks" musicals Literature-Film Quarterly. 31: 17-26.  0.047
2020 Roeker LE, Scarfo L, Chatzikonstantinou T, Abrisqueta P, Eyre TA, Cordoba R, Muntañola Prat A, Villacampa G, Leslie LA, Koropsak M, Quaresmini G, Allan JN, Furman RR, Bhavsar EB, Pagel JM, ... ... Ma S, et al. Worldwide Examination of Patients with CLL Hospitalized for COVID-19 Blood. 136: 45-49. DOI: 10.1182/BLOOD-2020-136408  0.047
1996 Ma S. A new formulation technique for local torque optimization of redundant manipulators Ieee Transactions On Industrial Electronics. 43: 462-468. DOI: 10.1109/41.510637  0.047
2018 Ye Z, Ding Y, Chen Z, Li Z, Ma S, Xu Z, Cheng L, Wang X, Zhang X, Ding N, Zhang Q, Qian Q. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies. Cancer Biology & Therapy. 1-6. PMID 30572767 DOI: 10.1080/15384047.2018.1538000  0.047
2023 Epperla N, Feng L, Shah NN, Fitzgerald L, Shah H, Stephens DM, Lee CJ, Ollila T, Shouse G, Danilov AV, David KA, Torka P, Hashmi H, Hess B, Barta SK, ... ... Ma S, et al. Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study. Journal of Hematology & Oncology. 16: 111. PMID 37946255 DOI: 10.1186/s13045-023-01508-3  0.047
2022 Wierda WG, Brown J, Abramson JS, Awan F, Bilgrami SF, Bociek G, Brander D, Chanan-Khan AA, Coutre SE, Davis RS, Eradat H, Fletcher CD, Gaballa S, Ghobadi A, Hamid MS, ... ... Ma S, et al. NCCN Guidelines® Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 622-634. PMID 35714675 DOI: 10.6004/jnccn.2022.0031  0.047
2012 Adekola KU, Liu V, Ma S, Rosen ST, Shanmugam M. Targeting Glucose Metabolism and Compensatory Metabolic Resistance in Chronic Lymphocytic Leukemia Blood. 120: 1801-1801. DOI: 10.1182/blood.v120.21.1801.1801  0.046
2023 Zhao F, Zou M, Wu H, Yao Y, Zhou M, Ma S, Xiao F, Abudushalamu G, Chen Y, Cai S, Yuan C, Fan X, Jiang X, Wu G. A simple and programmable dual-mode aptasensor for the ultrasensitive detection of multidrug-resistant bacteria. Biomaterials Science. PMID 36648428 DOI: 10.1039/d2bm01771g  0.046
2001 Ma SJ. Self-generated magnetic field by high frequency modulational field in plasma Wuli Xuebao/Acta Physica Sinica. 50: 1735-1736.  0.046
2017 Pettijohn EM, Ma S. Targeted Therapy in Chronic Lymphocytic Leukemia (CLL). Current Hematologic Malignancy Reports. PMID 28155013 DOI: 10.1007/s11899-017-0358-1  0.046
2015 Frankfurt O, Ma S, Gordon L, Winter JN, Horowitz JM, Rademaker A, Weitner BB, Peterson LC, Altman JK, Tallman MS, Petrich A, Rosen ST. Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes. Leukemia & Lymphoma. 56: 315-23. PMID 24707943 DOI: 10.3109/10428194.2014.910654  0.046
2020 Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, ... ... Ma S, et al. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 185-217. PMID 32023533 DOI: 10.6004/Jnccn.2020.0006  0.045
1998 Ma SX. Nitric oxide synthase in the gracile nucleus is increased by stimulus-evoked excitatory somatosympathetic reflexes Faseb Journal. 12.  0.045
2011 Tandon B, Peterson L, Gao J, Nelson B, Ma S, Rosen S, Chen YH. Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia/small lymphocytic lymphoma in small B-cell lymphomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 1433-43. PMID 21685909 DOI: 10.1038/modpathol.2011.103  0.045
2024 Sun N, Ma S, Jin L, Wang Y, Zhou C, Zhang X, Kang H, Yuan Y, Zhang Y, Yang H, Zhou M, Shu P. Unveiling the Anticancer Mechanism of Echinops davuricus: Isolation and Evaluation of AKR1B10 Inhibitors. Chemistry & Biodiversity. e202302053. PMID 38270380 DOI: 10.1002/cbdv.202302053  0.045
2000 Ma SY. Comparing the Russian state and the Chinese state: A literature review Problems of Post-Communism. 47: 3-12.  0.045
2015 Zhao X, Ma S, Liu N, Liu J, Wang W. A polysaccharide from Trametes robiniophila Murrill induces apoptosis through intrinsic mitochondrial pathway in human osteosarcoma (U-2 OS) cells. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. PMID 25666751 DOI: 10.1007/s13277-015-3185-9  0.045
1983 Ma Sk. One-dimensional Boltzmann equation with a three-body collision term Journal of Statistical Physics. 31: 107-114. DOI: 10.1007/BF01010924  0.044
1943 Ma ST. A relativistic formula for the scattering of mesons under the influence of radiation damping Mathematical Proceedings of the Cambridge Philosophical Society. 39: 168-172. DOI: 10.1017/S0305004100017849  0.044
2012 Ma S. Human face recognition method based on multi-linear functions Journal of Theoretical and Applied Information Technology. 45: 520-524.  0.044
1996 Ma S. Epicanthoplasty during double-fold eyelid operation [Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology. 32: 194-196. PMID 9590860  0.044
2006 Ma SC. Block-coded modulation based on set partitioning of block modulation codes 2006 Ieee Singapore International Conference On Communication Systems, Iccs 2006. DOI: 10.1109/ICCS.2006.301430  0.044
2002 Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK. Leukocyte transendothelial migration: a junctional affair. Seminars in Immunology. 14: 105-13. PMID 11978082 DOI: 10.1006/Smim.2001.0347  0.044
2007 Ma S, Krett NL, Rosen ST. NALP7 and NALP11 Differential Expression Correlates with Glucocorticoid Sensitivity in Multiple Myeloma Cell Lines. Blood. 110: 2366-2366. DOI: 10.1182/BLOOD.V110.11.2366.2366  0.044
1947 Ma ST. Further remarks on the redundant zeros in Heisenberg's theory of characteristic matrix [2] Physical Review. 71: 210. DOI: 10.1103/PhysRev.71.210  0.043
2023 Ma S, Li J, Ye H, Huang S, Huang Z, Wu D, Ma K, Xie J, Yin Y, Tan C. Effects of dietary supplementation of different levels of gamma-aminobutyric acid on reproductive performance, glucose intolerance and placental development of gilts. Journal of Animal Science. PMID 38133610 DOI: 10.1093/jas/skad405  0.043
2019 Sharman JP, Coutre SE, Furman RR, Cheson BD, Pagel JM, Hillmen P, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn IW, Ghia P, Eradat H, Ervin T, Lamanna N, Coiffier B, ... ... Ma S, et al. Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1801460. PMID 30995176 DOI: 10.1200/Jco.18.01460  0.043
2022 Ma S, Yan X. Application of BP Neural Networks in Garment Pattern Design System. Computational Intelligence and Neuroscience. 2022: 8766137. PMID 35592711 DOI: 10.1155/2022/8766137  0.043
1984 Ma SL. Partial difference sets Discrete Mathematics. 52: 75-89. DOI: 10.1016/0012-365X(84)90105-5  0.043
2022 Shen L, Zong W, Feng W, Chen E, Ma S, Yuan J, Wang G, Gu X, Shen X, Ju S. Upregulated Linc01836 in Serum Promisingly Serving as a Diagnostic and Prognostic Biomarker for Colorectal Cancer. Frontiers in Pharmacology. 13: 840391. PMID 35370745 DOI: 10.3389/fphar.2022.840391  0.042
1994 Ma SZ. Diagnosis and treatment of breast cystosarcoma phyllodes Chinese Journal of Clinical Oncology. 21: 679-681.  0.042
2013 Ma S. Design of sustainable energy supply for mechanical exoskeleton based on fuel cell Applied Mechanics and Materials. 312: 749-752. DOI: 10.4028/www.scientific.net/AMM.312.749  0.042
2023 Sun N, Ma S, Jin L, Wang Y, Zhou C, Zhang X, Kang H, Zhou M, Yang H, Shu P. Development of AKR1B10 inhibitors from Ajuga nipponensis based on diseases and targets. Fitoterapia. 105742. PMID 37952764 DOI: 10.1016/j.fitote.2023.105742  0.042
2002 Luscinskas FW, Ma S, Nusrat A, Parkos CA, Shaw SK. The role of endothelial cell lateral junctions during leukocyte trafficking. Immunological Reviews. 186: 57-67. PMID 12234362 DOI: 10.1034/J.1600-065X.2002.18606.X  0.042
2017 Wierda WG, Byrd JC, Abramson JS, Bhat S, Bociek G, Brander D, Brown J, Chanan-Khan A, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, ... ... Ma S, et al. Hairy Cell Leukemia, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 15: 1414-1427. PMID 29118233 DOI: 10.6004/Jnccn.2017.0165  0.041
2022 Zhang C, Guo M, Liu J, Ma S, Zhao H, Dong S, Sun W. A new method for screening and culture of Clostridium from pit mud under non-anaerobic conditions. Journal of Microbiological Methods. 200: 106559. PMID 36007702 DOI: 10.1016/j.mimet.2022.106559  0.041
2008 Ma S, Krett N, Rosen ST. Correlation of differential expression of NALP7 and NALP11 with glucocorticoid sensitivity in multiple myeloma cell lines. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 19516. PMID 27949399 DOI: 10.1200/jco.2008.26.15_suppl.19516  0.041
2022 Gu X, Zhang Y, Qin X, Ma S, Huang Y, Ju S. Transfer RNA-derived small RNA: an emerging small non-coding RNA with key roles in cancer. Experimental Hematology & Oncology. 11: 35. PMID 35658952 DOI: 10.1186/s40164-022-00290-1  0.041
2023 Mato AR, Woyach JA, Brown JR, Ghia P, Patel K, Eyre TA, Munir T, Lech-Maranda E, Lamanna N, Tam CS, Shah NN, Coombs CC, Ujjani CS, Fakhri B, Cheah CY, ... ... Ma S, et al. Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia. The New England Journal of Medicine. 389: 33-44. PMID 37407001 DOI: 10.1056/NEJMoa2300696  0.041
2016 Brown JR, Harb WA, Hill BT, Gabrilove J, Sharman JP, Schreeder MT, Barr PM, Foran JM, Miller TP, Burger JA, Kelly KR, Mahadevan D, Ma S, Li Y, Pierce DW, et al. Phase 1 study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed or refractory chronic lymphocytic leukemia. Haematologica. PMID 27151992 DOI: 10.3324/Haematol.2015.140806  0.041
1984 Ma SL. On rational circulants satisfying Am = dl + λJ Linear Algebra and Its Applications. 62: 155-161. DOI: 10.1016/0024-3795(84)90092-2  0.041
1999 Ma SY. The state, foreign capital and privatization in China Journal of Communist Studies and Transition Politics. 15: 54-79.  0.041
2000 Ma S, Triviños-Lagos L, Gräf R, Chisholm RL. Dynein intermediate chain mediated dynein-dynactin interaction is required for interphase microtubule organization and centrosome replication and separation in Dictyostelium. The Journal of Cell Biology. 147: 1261-74. PMID 10601339 DOI: 10.1083/Jcb.147.6.1261  0.041
2013 Krett NL, Ma S, Rosen ST. Clinical perspective on chemo-resistance and the role of RNA processing. Cancer Treatment and Research. 158: 235-45. PMID 24222361 DOI: 10.1007/978-3-642-31659-3_10  0.04
2021 Weng X, Mu Z, Wei X, Wang X, Zuo Q, Ma S, Ding Y, Wang X, Wu W, Craig PS, Wang Z. Correction to: The effects of dog management on Echinococcus spp. prevalence in villages on the eastern Tibetan Plateau, China. Parasites & Vectors. 14: 124. PMID 33637116 DOI: 10.1186/s13071-021-04637-1  0.04
2023 Yang H, Ma S, Zhao B, Deng J. Brightening up Full-Color and White Circularly Polarized Luminescence through Chiral Induction and Circularly Polarized Light Excitation. Acs Applied Materials & Interfaces. PMID 36857157 DOI: 10.1021/acsami.3c01145  0.04
2011 Ma S, Rosen ST. Signal transduction inhibitors in chronic lymphocytic leukemia. Current Opinion in Oncology. 23: 601-8. PMID 21892084 DOI: 10.1097/CCO.0b013e32834b8943  0.04
2022 Yan X, Ma S. Garment Design Models Combining Bayesian Classifier and Decision Tree Algorithm. Computational Intelligence and Neuroscience. 2022: 1904158. PMID 35669635 DOI: 10.1155/2022/1904158  0.04
2009 Ma SM. Resolution of operator singularities via the mixed-variable method Publications of the Research Institute For Mathematical Sciences. 45: 569-599. DOI: 10.2977/prims/1241553130  0.04
1993 Ma S. Severe acute pancreatitis and ARDS Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 31: 517-520. PMID 8033713  0.04
2019 Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, ... ... Ma S, et al. NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 12-20. PMID 30659125 DOI: 10.6004/Jnccn.2019.0002  0.039
2020 Ma S, Kong S, Wang F, Ju S. CircRNAs: biogenesis, functions, and role in drug-resistant Tumours. Molecular Cancer. 19: 119. PMID 32758239 DOI: 10.1186/s12943-020-01231-4  0.039
2019 Stasiłojć G, Felberg A, Urban A, Kowalska D, Ma S, Blom AM, Lundin J, Österborg A, Okrój M. Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies. Journal of Immunological Methods. 112675. PMID 31629742 DOI: 10.1016/j.jim.2019.112675  0.039
2022 Zurko JC, Nizamuddin I, Epperla N, David KA, Cohen JB, Moyo T, Ollila TA, Hess BT, Roy I, Ferdman R, Liu J, Chowdhury SM, Romancik JT, Bhansali RS, Harris EI, ... ... Ma S, et al. Peri-CAR-T practice patterns and survival predictors for all CAR-T patients and post-CAR-T failure in aggressive B-NHL. Blood Advances. PMID 36094847 DOI: 10.1182/bloodadvances.2022008240  0.039
2021 Gu X, Ma S, Liang B, Ju S. Serum hsa_tsr016141 as a Kind of tRNA-Derived Fragments Is a Novel Biomarker in Gastric Cancer. Frontiers in Oncology. 11: 679366. PMID 34055648 DOI: 10.3389/fonc.2021.679366  0.039
2008 Ma S. Heterocycles based on the chemistry of alkylidenecyclopropanes and (aza)-cyclopropenes Pure and Applied Chemistry. 80: 695-706. DOI: 10.1351/pac200880040695  0.038
2022 Li M, Ma S, Liu Z. A novel method to detect the early warning signal of COVID-19 transmission. Bmc Infectious Diseases. 22: 626. PMID 35850664 DOI: 10.1186/s12879-022-07603-z  0.038
1989 Ma SH. Infusion of sclerosant through direct cannulation of the coronary vein in the prevention and treatment of esophageal varices bleeding in portal hypertension Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 27: 105-106, 126. PMID 2789126  0.038
2015 Ma S, Platanias LC. Rituximab and glucocorticoids: friends or foes? It is all about timing. Leukemia & Lymphoma. 56: 2237-8. PMID 25707289 DOI: 10.3109/10428194.2015.1022772  0.038
1998 Ma SX. Do mechanosensitive (Stretch-Activated) ion channels play a role in mediating the response to acupuncture needling? American Journal of Acupuncture. 26: 63-68.  0.037
1986 Ma SS. Role of lidocaine in protecting central neurons from ischemic or anoxic damage Zhonghua Yi Xue Za Zhi. 66: 544-546. PMID 3098376  0.037
1992 Ma SY. China's higher education reform and the emergence of dissidence: The Case of Chen Kuide China Information. 7: 39-45. DOI: 10.1177/0920203X9200700304  0.037
2019 Schieber M, Ma S. The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma. Blood and Lymphatic Cancer : Targets and Therapy. 9: 9-17. PMID 32009829 DOI: 10.2147/BLCTT.S177009  0.037
2023 Huang S, Wu D, Hao X, Nie J, Huang Z, Ma S, Chen Y, Chen S, Wu J, Sun J, Ao H, Gao B, Tan C. Dietary fiber supplementation during the last 50 days of gestation improves the farrowing performance of gilts by modulating insulin sensitivity, gut microbiota and placental function. Journal of Animal Science. PMID 36634095 DOI: 10.1093/jas/skad021  0.037
2001 Ma SM. Organometallic chemistry directed towards organic synthesis - Our own story Chinese Journal of Organic Chemistry. 21: 833-841.  0.037
1985 Ma SL. Polynomial addition sets and polynomial digraphs Linear Algebra and Its Applications. 69: 213-230. DOI: 10.1016/0024-3795(85)90077-1  0.036
2013 Trifilio S, Ma S, Petrich A. Reduced-dose carboxypeptidase-G2 successfully lowers elevated methotrexate levels in an adult with acute methotrexate-induced renal failure. Clinical Advances in Hematology & Oncology : H&O. 11: 322-3. PMID 23880719  0.036
1973 Ma SK. The renormalization group and the large n limit Journal of Mathematical Physics. 15: 1866-1891.  0.036
1953 Ma ST. Interpretation of the virtual level of the deuteron Reviews of Modern Physics. 25: 853-860. DOI: 10.1103/RevModPhys.25.853  0.036
1950 Ma ST. Quantum theory of the longitudinal electromagnetic field Physical Review. 80: 729-732. DOI: 10.1103/PhysRev.80.729  0.036
1994 Ma SL. On subsets of partial difference sets Discrete Mathematics. 125: 263-272. DOI: 10.1016/0012-365X(94)90167-8  0.036
2022 Li H, Feng X, Li H, Ma S, Song W, Yang B, Jiang T, Yang C. The Supplement of Magnesium Element to Inhibit Colorectal Tumor Cells. Biological Trace Element Research. PMID 36006540 DOI: 10.1007/s12011-022-03393-2  0.036
2010 Ma S. China's "left behind" children often suffer health consequences. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 182: E731-2. PMID 20921257 DOI: 10.1503/cmaj.109-3674  0.036
2014 Ma SG. The research of next-gen game engine virtual reality in actual project Applied Mechanics and Materials. 443: 39-43. DOI: 10.4028/www.scientific.net/AMM.443.39  0.036
2023 Yao Y, Zou M, Wu H, Ma S, Gu X, Zhou M, Zhao F, Abudushalamua G, Xiao F, Chen Y, Cai S, Fan X, Wu G. A colloidal gold test strip based on catalytic hairpin assembly for the clinical detection of influenza a virus nucleic acid. Talanta. 265: 124855. PMID 37406394 DOI: 10.1016/j.talanta.2023.124855  0.036
2012 Ma S. The Development of FtsZ Inhibitors as Potential Antibacterial Agents Chemmedchem. 7: 1161-1172. PMID 22639193 DOI: 10.1002/cmdc.201200156  0.036
1985 Ma SX. Preliminary study on the antiarrhythmic action of the alkaloids of Corydalis yanhusuo Zhong Yao Tong Bao (Beijing, China : 1981). 10: 41-42. PMID 2938792  0.035
2023 Odetola O, Ma S. Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL). Current Hematologic Malignancy Reports. 1-14. PMID 37278884 DOI: 10.1007/s11899-023-00700-z  0.035
2005 Ma S. Some typical advances in the synthetic applications of allenes Chemical Reviews. 105: 2829-2871. DOI: 10.1021/Cr020024J  0.035
2022 Wu Z, Rao S, Li J, Ding N, Chen J, Feng L, Ma S, Hu C, Dai H, Wen L, Jiang Q, Deng J, Deng M, Tan C. Dietary adenosine 5'-monophosphate supplementation increases food intake and remodels energy expenditure in mice. Food & Nutrition Research. 66. PMID 35844957 DOI: 10.29219/fnr.v66.7680  0.035
2022 Yang K, Ma S, Zhang Y, Zhao B, Deng J. Helix-Sense-Selective Polymerization of Achiral Monomers for the Preparation of Chiral Helical Polyacetylenes Showing Intense CPL in Solid Film State. Macromolecular Rapid Communications. e2200111. PMID 35429085 DOI: 10.1002/marc.202200111  0.035
2023 Huang Z, Yang Y, Ma S, Li J, Ye H, Chen Q, Li Z, Deng J, Tan C. KLF4 down-regulation underlies placental angiogenesis impairment induced by maternal glucose intolerance in late pregnancy. The Journal of Nutritional Biochemistry. 109509. PMID 37907170 DOI: 10.1016/j.jnutbio.2023.109509  0.035
2021 Small S, Ma S. Frontline Treatment for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): Targeted Therapy vs. Chemoimmunotherapy. Current Hematologic Malignancy Reports. PMID 34021874 DOI: 10.1007/s11899-021-00637-1  0.035
2017 Ma S, Chen C, Cao T, Bi Y, Zhou J, Li X, Yu D, Li S. Mitigation Effect of Proanthocyanidin on Secondary Heart Injury in Rats Caused by Mechanical Trauma. Scientific Reports. 7: 44623. PMID 28294148 DOI: 10.1038/srep44623  0.035
2013 Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn I, Ghia P, Eradat H, Ervin T, Lamanna N, Hallek M, ... ... Ma S, et al. A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Idelalisib and Rituximab for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL) Blood. 122: LBA-6-LBA-6. DOI: 10.1182/BLOOD.V122.21.LBA-6.LBA-6  0.035
2010 Kim YC, Jung YC, Chen J, Alhasan AH, Kaewsaard P, Zhang Y, Ma S, Rosen S, Wang SM. Evidences showing wide presence of small genomic aberrations in chronic lymphocytic leukemia. Bmc Research Notes. 3: 341. PMID 21172017 DOI: 10.1186/1756-0500-3-341  0.035
2022 Ma S, Rosen ST, Winqvist M, Frankfurt O, Winter JN, Gordon L, Helenowski I, Zhang H, Kreutzer J, Sönnert-Husa S, Österborg A, Lundin J. Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study. Leukemia Research. 122: 106945. PMID 36115087 DOI: 10.1016/j.leukres.2022.106945  0.035
2017 Seymour JF, Ma S, Brander DM, Choi MY, Barrientos J, Davids MS, Anderson MA, Beaven AW, Rosen ST, Tam CS, Prine B, Agarwal SK, Munasinghe W, Zhu M, Lash LL, et al. Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study. The Lancet. Oncology. PMID 28089635 DOI: 10.1016/S1470-2045(17)30012-8  0.035
2021 Roeker LE, Eyre TA, Thompson MC, Lamanna N, Coltoff A, Davids MS, Baker P, Leslie LA, Rogers KA, Allan JN, Cordoba R, Lopez-Garcia A, Antic D, Pagel JM, Martinez-Calle N, ... ... Ma S, et al. COVID-19 in patients with CLL: improved survival outcomes and update on management strategies. Blood. PMID 34297826 DOI: 10.1182/blood.2021011841  0.034
2023 Siddiqi T, Maloney DG, Kenderian SS, Brander DM, Dorritie K, Soumerai J, Riedell PA, Shah NN, Nath R, Fakhri B, Stephens DM, Ma S, Feldman T, Solomon SR, Schuster SJ, et al. Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1-2 study. Lancet (London, England). PMID 37295445 DOI: 10.1016/S0140-6736(23)01052-8  0.034
2003 Ma S. Transition metal-catalyzed/mediated reaction of allenes with a nucleophilic functionality connected to the α-carbon atom Accounts of Chemical Research. 36: 701-712. DOI: 10.1021/ar020133k  0.034
2020 Ma S, Kang Z. Sequence analysis of mitochondrial genome of the false and phantom crane-fly Kang, Yao and Yang, 2013 (Diptera, Ptychopteridae). Mitochondrial Dna. Part B, Resources. 5: 2767-2769. PMID 33457942 DOI: 10.1080/23802359.2020.1788452  0.034
2022 Wu DY, Feng L, Hao XY, Huang SB, Wu ZF, Ma S, Yin YL, Tan CQ. Effects of dietary supplementation of gestating sows with adenosine 5 '-monophosphate or adenosine on placental angiogenesis and vitality of their offspring. Journal of Animal Science. PMID 35781577 DOI: 10.1093/jas/skac237  0.033
1947 Ma ST. Relativistic invariance of the quantum theory of radiation Physical Review. 72: 1090-1096. DOI: 10.1103/PhysRev.72.1090  0.033
2012 Ma S. A digital image compression algorithm based on gene expressions International Review On Computers and Software. 7: 2555-2559.  0.033
2022 Shen X, Kong S, Ma S, Shen L, Zheng M, Qin S, Qi J, Wang Q, Cui X, Ju S. Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis. Oncogene. PMID 36109630 DOI: 10.1038/s41388-022-02449-w  0.033
2022 Qin X, Chen Y, Ma S, Shen L, Ju S. Immune-related gene TM4SF18 could promote the metastasis of gastric cancer cells and predict the prognosis of gastric cancer patients. Molecular Oncology. PMID 36209368 DOI: 10.1002/1878-0261.13321  0.033
2014 Furman RR, Sharman JP, Coutre SE, Cheson BD, Pagel JM, Hillmen P, Barrientos JC, Zelenetz AD, Kipps TJ, Flinn I, Ghia P, Eradat H, Ervin T, Lamanna N, Coiffier B, ... ... Ma S, et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. The New England Journal of Medicine. 370: 997-1007. PMID 24450857 DOI: 10.1056/NEJMoa1315226  0.033
2023 Zhou M, Yao Y, Ma S, Zou M, Chen Y, Cai S, Zhao F, Wu H, Xiao F, Abudushalamu G, Fan X, Wu G. Dual-targeted and dual-sensitive self-assembled protein nanocarrier delivering hVEGI-192 for triple-negative breast cancer. International Journal of Biological Macromolecules. 125475. PMID 37353129 DOI: 10.1016/j.ijbiomac.2023.125475  0.032
2023 Ma S, Zhou M, Xu Y, Gu X, Zou M, Abudushalamu G, Yao Y, Fan X, Wu G. Clinical application and detection techniques of liquid biopsy in gastric cancer. Molecular Cancer. 22: 7. PMID 36627698 DOI: 10.1186/s12943-023-01715-z  0.032
1982 Ma S. Selective hepatic arteriography in the diagnosis of liver cancer Zhonghua Yi Xue Za Zhi. 62: 717-719. PMID 6820318  0.032
2007 Ma S. Additive risk model with case-cohort sampled current status data Statistical Papers. 48: 595-608. DOI: 10.1007/s00362-007-0359-y  0.032
2020 Weng X, Mu Z, Wei X, Wang X, Zuo Q, Ma S, Ding Y, Wang X, Wu W, Craig PS, Wang Z. The effects of dog management on Echinococcus spp. prevalence in villages on the eastern Tibetan Plateau, China. Parasites & Vectors. 13: 207. PMID 32317015 DOI: 10.1186/s13071-020-04082-6  0.032
2022 Roy I, Smilnak G, Burkart M, Hamilton E, Thorp K, Miyata S, Ma S, Pro B, Winter J, Gordon L, Karmali R. Cachexia is a risk factor for negative clinical and functional outcomes in patients receiving chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma. British Journal of Haematology. PMID 35141891 DOI: 10.1111/bjh.18054  0.032
2023 Wallace DS, Rowland C, Hill BT, Baran AM, Casulo C, Reagan PM, Winter A, Karmali R, Winter JN, Gordon LI, Bui A, Sportelli P, Miskin HP, Weiss MS, Friedberg JW, ... Ma S, et al. Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma. Leukemia & Lymphoma. 1-4. PMID 37341984 DOI: 10.1080/10428194.2023.2223743  0.032
2001 Ma SY. China's B-Share Market Reform: Capital Market Liberalization under Imperfect Currency Convertibility Issues and Studies. 37: 149-161.  0.032
2017 Regan JA, Petrich AM, Dispenza MC, Ma S, Gordon LI, Bochner BS. Ibrutinib, a BTK inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity in allergic cancer patients receiving drug The Journal of Allergy and Clinical Immunology. 139. DOI: 10.1016/J.Jaci.2016.12.748  0.031
2011 Ma S. China searches for best medicine for ailing scientific journals. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 183: E25-6. PMID 21098072 DOI: 10.1503/cmaj.109-3736  0.031
2008 Ma Sx. Biochemical physiology of nitric oxide over acupuncture points and meridians: new approach and perspectives Zhen Ci Yan Jiu = Acupuncture Research / [Zhongguo Yi Xue Ke Xue Yuan Yi Xue Qing Bao Yan Jiu Suo Bian Ji]. 33: 47-48. PMID 18386645  0.03
1953 Ma ST. Power-series expansion of the unitary operator U(t, t0) Physical Review. 91: 392. DOI: 10.1103/PhysRev.91.392  0.03
2019 Ma S, Li X, Wang X, Cheng L, Li Z, Zhang C, Ye Z, Qian Q. Current Progress in CAR-T Cell Therapy for Solid Tumors. International Journal of Biological Sciences. 15: 2548-2560. PMID 31754328 DOI: 10.7150/ijbs.34213  0.029
2016 Wang D, Li Z, Zhang Y, Wang G, Wei M, Hu Y, Ma S, Jiang Y, Che N, Wang X, Yao J, Yin J. Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade. Epilepsia. PMID 26945677 DOI: 10.1111/epi.13348  0.029
2016 Choi M, Brander D, Roberts AW, Seymour JF, Kipps TJ, Barrientos JC, Davids MS, Anderson MA, Tam C, Prine B, Cornejo C, Zhu M, Lash L, Kim SY, Ma S. Venetoclax Plus Rituximab can Achieve Durable Treatment-Free Remission in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Clinical Lymphoma Myeloma and Leukemia. 16: S50-S51. DOI: 10.1016/J.CLML.2016.07.073  0.029
2014 Ma S. File management system of electronic government affairs Journal of Chemical and Pharmaceutical Research. 6: 162-169.  0.029
2024 Shang X, Liu J, Zhu Z, Zhang X, Huang Y, Liu S, Wang W, Zhang X, Ma S, Tang S, Hu Y, Ge Z, Yu H, He M. Metabolomic age and risk of 50 chronic diseases in community-dwelling adults: A prospective cohort study. Aging Cell. e14125. PMID 38380547 DOI: 10.1111/acel.14125  0.029
1952 Ma ST. Bound states and the interaction representation [15] Physical Review. 88: 1211. DOI: 10.1103/PhysRev.88.1211  0.029
2019 Pu Z, Ma S, Wang L, Li M, Shang L, Luo Y, Chen W. Corrigendum to "Amyloid-beta Degradation and Neuroprotection of Dauricine Mediated by Unfolded Protein Response in a Caenorhabditis elegans Model of Alzheimer's Disease" [Neuroscience 392C (2018) 25-37]. Neuroscience. PMID 30811972 DOI: 10.1016/j.neuroscience.2019.01.048  0.028
2022 Zhang Y, Yang S, Jiang D, Li Y, Ma S, Wang L, Li G, Wang H, Zhang A, Xu G. Screening and identification of an anti-PD-1 nanobody with antitumor activity. Bioscience Reports. PMID 36475449 DOI: 10.1042/BSR20221546  0.028
1986 Ma SY. Recent Changes in China's Pure Trade Theory The China Quarterly. 106: 291-305. DOI: 10.1017/S0305741000038583  0.027
1990 Ma SL. On divisible difference sets which are fixed by the inverse Archiv Der Mathematik. 54: 409-416. DOI: 10.1007/BF01189590  0.027
1956 Ma ST. On the vacuum current Nuclear Physics. 1: 112-118.  0.027
2020 Wang XJ, Jiao Y, Ma S, Yang JT, Wang ZX. Whole-Genome Sequencing: An Effective Strategy for Insertion Information Analysis of Foreign Genes in Transgenic Plants. Frontiers in Plant Science. 11: 573871. PMID 33335534 DOI: 10.3389/fpls.2020.573871  0.026
2003 Ma Sp. Is department of medicine necessary Zhonghua Nei Ke Za Zhi [Chinese Journal of Internal Medicine]. 42: 827-828. PMID 15040314  0.026
2013 Ma S. A tale of new Mr. Braggadocio": Narrative subjectivity and brain electricity in late qing science fiction Science-Fiction Studies. 40: 55-72.  0.026
1949 Ma ST. Relativistic formulation of the quantum theory of radiation Physical Review. 75: 535. DOI: 10.1103/PhysRev.75.535  0.026
1992 Ma SY. Nationalism: State-building or state-destroying? The Social Science Journal. 29: 293-305. DOI: 10.1016/0362-3319(92)90023-B  0.026
1993 Ma SK. A dangerous game: Deng and the intellectuals Journal of Contemporary China. 2: 53-68. DOI: 10.1080/10670569308724164  0.025
1951 Ma ST. Retarded nuclear interaction [20] Physical Review. 82: 275-276. DOI: 10.1103/PhysRev.82.275.2  0.025
1996 Ma SY. The role of power struggle and economic changes in the 'Heshang phenomenon' in China Modern Asian Studies. 30: 29-50.  0.025
2009 Krett N, Ma S. Overcoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine? Leukemia & Lymphoma. 50: 689-90. PMID 19330651 DOI: 10.1080/10428190902847708  0.025
2023 Zhang X, Kong L, Liu S, Zhang X, Shang X, Zhu Z, Huang Y, Ma S, Jason H, Kiburg KV, Zheng C, Hu Y, Li C, Wu G, Liang Y, et al. EBD: an eye biomarker database. Bioinformatics (Oxford, England). PMID 37052519 DOI: 10.1093/bioinformatics/btad194  0.025
2017 Boddy C, Galvez C, Pro B, Fought A, Gordon L, Winter J, Ma S, Karmali R, Kaplan J. Outcomes with DA-EPOCH-R in the Treatment of Aggressive B Cell Lymphoma Clinical Lymphoma, Myeloma & Leukemia. 17. DOI: 10.1016/J.Clml.2017.07.199  0.025
2004 Ma S. Recent advances in transition metal-catalyzed or -mediated cyclization of 2,3-allenoic acids: New methodologies for the synthesis of butenolides Pure and Applied Chemistry. 76: 651-656.  0.024
1993 Ma S. Experimental study on the effect of unilateral mastication on the morphology of mandibular joint Zhonghua Kou Qiang Yi Xue Za Zhi = Zhonghua Kouqiang Yixue Zazhi = Chinese Journal of Stomatology. 28: 151-153. PMID 8275806 DOI: 10.1108/S0163-2396(2009)0000033012  0.024
2015 Sun Y, Luo X, Yang K, Sun X, Li X, Zhang C, Ma S, Liu Y, Yin J. Neural overexpression of multidrug resistance-associated protein 1 and refractory epilepsy: A meta-analysis of 9 studies. The International Journal of Neuroscience. 1-26. PMID 26000815 DOI: 10.3109/00207454.2015.1015724  0.024
2015 Adekola KU, Dalva Aydemir S, Ma S, Zhou Z, Rosen ST, Shanmugam M. Investigating and targeting chronic lymphocytic leukemia metabolism with the human immunodeficiency virus protease inhibitor ritonavir and metformin. Leukemia & Lymphoma. 56: 450-9. PMID 24828872 DOI: 10.3109/10428194.2014.922180  0.024
2015 Zhao X, Ma S, Liu N, Liu J, Wang W. A polysaccharide from Trametes robiniophila inhibits human osteosarcoma xenograft tumor growth in vivo. Carbohydrate Polymers. 124: 157-63. PMID 25839806 DOI: 10.1016/j.carbpol.2015.02.016  0.024
1995 Ma SY. Shareholding System Reform: The Chinese Way of Privatisation Communist Economies and Economic Transformation. 7: 159-174. DOI: 10.1080/14631379508427817  0.023
2013 Sun H, Tian H, Yang Y, Xie D, Zhang YC, Liu X, Ma S, Zhao HM, Ren TL. A novel flexible nanogenerator made of ZnO nanoparticles and multiwall carbon nanotube. Nanoscale. 5: 6117-23. PMID 23728508 DOI: 10.1039/c3nr00866e  0.023
2015 Ma S. A flying start to a bright future Organic Chemistry Frontiers. 2: 9-11. DOI: 10.1039/c4qo90042a  0.023
1990 Ma SM. [The developmental survey of bacteriology in Meiji period of Japan] (Chi) Zhonghua Yi Shi Za Zhi (Beijing, China : 1980). 20: 166-169. PMID 11622784  0.023
2023 Rao S, Cui Z, Zhang L, Ma S, Huang S, Feng L, Chen Y, Luo J, Li J, Qian S, Liu H, Liu Y, Yang L, Yin Y, Tan C. Effects of dietary adenosine and adenosine 5'-monophosphate supplementation on carcass characteristics, meat quality, and lipid metabolism in adipose tissues of finishing pigs. Meat Science. 201: 109174. PMID 37054497 DOI: 10.1016/j.meatsci.2023.109174  0.023
2004 Ma S. Pd-catalyzed coupling reactions involving propargylic/allenylic species European Journal of Organic Chemistry. 1175-1183. DOI: 10.1002/ejoc.200300352  0.023
2021 Ma S, Gu X, Shen L, Chen Y, Qian C, Shen X, Ju S. CircHAS2 promotes the proliferation, migration, and invasion of gastric cancer cells by regulating PPM1E mediated by hsa-miR-944. Cell Death & Disease. 12: 863. PMID 34556632 DOI: 10.1038/s41419-021-04158-w  0.022
2023 Doukas PG, St Pierre F, Karmali R, Mi X, Boyer J, Nieves M, Ison MG, Winter JN, Gordon LI, Ma S. Humoral Immunity After COVID-19 Vaccination in Chronic Lymphocytic Leukemia and Other Indolent Lymphomas: A Single-Center Observational Study. The Oncologist. PMID 37141401 DOI: 10.1093/oncolo/oyad121  0.022
2019 Ma S, Chan R, Xing G, Ye W, Brubaker C, Raj N, Ruzicka B, Wagner-Johnston N. Survival Outcomes Following Idelalisib Interruption in the Treatment of Relapsed or Refractory Indolent Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia Clinical Lymphoma Myeloma and Leukemia. 19: S313. DOI: 10.1016/j.clml.2019.07.284  0.022
1944 Ma SY. Experimentelle Untersuchungen über Hitzemodifikationen des Flügels von Drosophila melanogaster Wilhelm Roux' Archiv FüR Entwicklungsmechanik Der Organismen. 142: 508-618. DOI: 10.1007/BF00596682  0.022
2007 Ma S, Rosen ST. Enzastaurin. Current Opinion in Oncology. 19: 590-5. PMID 17906457 DOI: 10.1097/CCO.0b013e3282f10a00  0.022
2018 Boddy CS, Ma S. Frontline Therapy of CLL: Evolving Treatment Paradigm. Current Hematologic Malignancy Reports. PMID 29480432 DOI: 10.1007/s11899-018-0438-x  0.022
1940 Ma ST. The electrostatic dipole moment of a nucleus in the meson theory Mathematical Proceedings of the Cambridge Philosophical Society. 36: 438-440. DOI: 10.1017/S0305004100017473  0.022
1949 Ma ST. Vacuum polarization [7] Physical Review. 75: 1264-1265. DOI: 10.1103/PhysRev.75.1264.2  0.021
1989 Ma SY. Diagnosis of intraocular foreign body by computed tomography [Chung-Hua Yen K"O Tsa Chih] Chinese Journal of Ophthalmology. 25: 2-5. PMID 2503335  0.021
2023 Ma S, Ma H, Yang K, Tan Z, Zhao B, Deng J. Intense Circularly Polarized Fluorescence and Room-Temperature Phosphorescence in Carbon Dots/Chiral Helical Polymer Composite Films. Acs Nano. 17: 6912-6921. PMID 37000903 DOI: 10.1021/acsnano.3c00713  0.021
2003 Ma S. Study on the inter-form cooperation modes on supply chain under the demand fluctuation situations Gaojishu Tongxin/High Technology Letters. 13: 67.  0.021
1989 Ma SL. Schur rings and cyclic association schemes of class three Graphs and Combinatorics. 5: 355-361. DOI: 10.1007/BF01788691  0.021
2017 McMahon KM, Scielzo C, Angeloni NL, Deiss-Yehiely E, Scarfo L, Ranghetti P, Ma S, Kaplan J, Barbaglio F, Gordon LI, Giles FJ, Shad Thaxton C, Ghia P. Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia. Oncotarget. PMID 28061439 DOI: 10.18632/Oncotarget.14494  0.021
2022 Behdad A, Schipma MJ, Ma S, Chen YH, Chen QC. Distinct immune-response profile of Richter transformation chronic lymphocytic leukemia (CLL), defined by high expression of PD1, LAG3, TIM3 and IL-10. Leukemia & Lymphoma. 1-5. PMID 36102789 DOI: 10.1080/10428194.2022.2123236  0.021
1961 MA SC. A study on the radiosensitivity of mouse during various phases of the oestrous cycle Scientia Sinica. 10: 860-866. PMID 14467688  0.021
1985 Ma SL. On multipliers of polynomial addition sets Linear Algebra and Its Applications. 69: 231-238. DOI: 10.1016/0024-3795(85)90078-3  0.021
2021 Zhou SJ, Liu ZY, Xiong SL, Ma S, Huang YH, Lei Y, Cao MH, Tu SX. [Screening of Amendments for Simultaneous Cd and As Immobilization in Soil]. Huan Jing Ke Xue= Huanjing Kexue. 42: 3527-3534. PMID 34212679 DOI: 10.13227/j.hjkx.202010022  0.021
2013 Roberts MJ, Chadburn A, Ma S, Hyjek E, Peterson LC. Nuclear protein dysregulation in lymphoplasmacytic lymphoma/waldenstrom macroglobulinemia. American Journal of Clinical Pathology. 139: 210-9. PMID 23355206 DOI: 10.1309/AJCP0YGM8BLFYHJY  0.021
2007 Ma S. Information asymmetry and valuation uncertainty, the determination of China's IPO allocation procedures Applied Financial Economics. 17: 271-284. DOI: 10.1080/09603100600735351  0.02
2020 Ma S, Sun K, Zhang M, Zhou X, Zheng X, Tian S, Liu Y, Chen L, Gao X, Ye J, Zhou X, Wang J, Han Y. Disruption of Plin5 degradation by CMA causes lipid homeostasis imbalance in NAFLD. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 32339374 DOI: 10.1111/liv.14492  0.02
2006 Ma S. Transition-metal-catalyzed reactions of allenes Pure and Applied Chemistry. 78: 197-208. DOI: 10.1351/pac200678020197  0.019
1992 Ma S. The effects of nitroglycerin on refractory congestive heart failure by intravenous infusion Chinese Journal of Cardiology. 20: 160-162+195. PMID 1289026  0.019
2019 Lentz R, Feinglass J, Ma S, Akhter N. Risk factors for the development of atrial fibrillation on ibrutinib treatment. Leukemia & Lymphoma. 1-7. PMID 30730240 DOI: 10.1080/10428194.2018.1533129  0.019
2021 Ma S, Kong S, Gu X, Xu Y, Tao M, Shen L, Shen X, Ju S. As a biomarker for gastric cancer, circPTPN22 regulates the progression of gastric cancer through the EMT pathway. Cancer Cell International. 21: 44. PMID 33430866 DOI: 10.1186/s12935-020-01701-1  0.018
2023 Gulinaizhaer A, Zou M, Ma S, Yao Y, Fan X, Wu G. Isothermal nucleic acid amplification technology in HIV detection. The Analyst. PMID 36825492 DOI: 10.1039/d2an01813f  0.018
2018 Behdad A, Griffin B, Chen YH, Ma S, Kelemen K, Lu X, Chen QC. PD-1 is highly expressed by neoplastic B-cells in Richter transformation. British Journal of Haematology. PMID 30028010 DOI: 10.1111/bjh.15514  0.017
2011 Ma S. China struggles to rebuild mental health programs. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 183: E89-90. PMID 21220446 DOI: 10.1503/cmaj.109-3738  0.017
2023 Zhang M, Tian S, Ma S, Zhou X, Zheng X, Li B, Guo G, Yu J, Su R, Yang F, Hu Y, Ma G, Yang H, Zheng L, Guo C, et al. Deficient Chaperone-Mediated Autophagy in Macrophage Aggravates Inflammation of Nonalcoholic Steatohepatitis by Targeting Nup85. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 36912786 DOI: 10.1111/liv.15547  0.017
2001 Ma SY. Study of visible electroluminescence from Au/(Si/SiO2 superlattices)/p-Si structure Lanzhou Daxue Xuebao/Journal of Lanzhou University. 37: 40.  0.017
2011 Ma S. Preface Topics in Organometallic Chemistry. 36.  0.017
2023 Yang Q, Kong S, Yu J, Xu Y, Tao M, Ma S, Tang C, Shen X, Tang Z, Ju S. MicroRNA miR-1275 coordinately regulates AEA/LPA signals via targeting FAAH in lipid metabolism reprogramming of gastric cancer. Cell Death & Disease. 14: 62. PMID 36702852 DOI: 10.1038/s41419-023-05584-8  0.017
2015 Dimopoulos MA, Leleu X, Matous J, MacDonald D, Trotman J, Oriol A, Shustik C, Tedeschi A, Garcia-Sanz R, Heffner LT, Ma S, Mahe B, Tam C, Tournilhac O, Li J, et al. A randomized, double-blind, placebo-controlled, phase 3 study of rituximab with or without ibrutinib for Waldenstrom’s macroglobulinemia (PCYC-1127-CA). Journal of Clinical Oncology. 33: TPS8599-TPS8599. DOI: 10.1200/JCO.2015.33.15_SUPPL.TPS8599  0.016
1990 Ma SX. Proton inducted X-ray emission analysis of food samples Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 24: 223-226. PMID 2209268  0.016
2020 Barnea Slonim L, Ma S, Behdad A, Chen Q. Pseudo-Richter transformation of chronic lymphocytic leukaemia/small lymphocytic lymphoma following ibrutinib interruption: a diagnostic pitfall. British Journal of Haematology. PMID 32677079 DOI: 10.1111/bjh.16948  0.016
2013 Ma S. Research on project management of dcs development for first AP1000 unit International Conference On Nuclear Engineering, Proceedings, Icone. 5. DOI: 10.1115/ICONE21-15541  0.016
2007 Ma S. Control of regio- and stereoselectivity in electrophilic addition reactions of allenes Pure and Applied Chemistry. 79: 261-267. DOI: 10.1351/Pac200779020261  0.015
2022 Aqil B, Kaur A, Ramos J, Sukhanova M, Ma S, Gao J, Lu X, Chen YH, Chen Q. Richter transformation to aggressive plasmablastic neoplasm related to selection of a -mutated clone in a patient with CLL/SLL treated by ibrutinib. Leukemia & Lymphoma. 1-4. PMID 36336991 DOI: 10.1080/10428194.2022.2140286  0.015
1940 Ma ST. Photomagnetic disintegration and magnetic moment of the deuteron in the meson theory Mathematical Proceedings of the Cambridge Philosophical Society. 36: 351-362. DOI: 10.1017/S0305004100017382  0.015
1986 Ma S. Comparative analysis of the index of our population life quality Ren Kou Yan Jiu = Renkou Yanjiu. 31-33, 52. PMID 12280624  0.014
2014 Ma S, Seymour JF, Lanasa MC, Kipps TJ, Barrientos JC, Davids MS, Mason-Bright T, Rudersdorf N, Yang J, Munasinghe W, Zhu M, Cerri E, Enschede SH, Humerickhouse R, Roberts AW. ABT-199 (GDC-0199) combined with rituximab (R) in patients (pts) with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): Interim results of a phase 1b study. Journal of Clinical Oncology. 32: 7013-7013. DOI: 10.1200/JCO.2014.32.15_SUPPL.7013  0.013
2020 Pearse W, Kaplan J, Gorgdon L, Karmali R, Winter J, Ma S, Behdad A, Klein A, Petrich A, Jovanovic B, Helenowski I, Palmer B, Smith S, Evens A, Pro B. ABCL-283: A Phase I/II Trial of Brentuximab Vedotin (BV) Plus Rituximab (R) as Frontline Therapy for Patients with Immunosuppression-Associated CD30+ and/or EBV+ Lymphomas Clinical Lymphoma Myeloma and Leukemia. 20: S271. DOI: 10.1016/s2152-2650(20)30885-5  0.013
2010 Ma S. Affluence prompts more women in China to light up. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 182: E557-8. PMID 20643842 DOI: 10.1503/cmaj.109-3307  0.013
2004 Ma SM. A fast algorithm for curve singularities Bulletin of the Australian Mathematical Society. 69: 403-414.  0.012
2021 Handunnetti S, Anderson MA, Roberts AW, Davids MS, Ma S, Boyer M, Arzt J, Masud AA, Popovic R, Jacobson A, Kim SY, Seymour JF. Addition of rituximab in relapsed/refractory chronic lymphocytic leukemia after progression on venetoclax monotherapy Ejhaem. 2: 266-271. DOI: 10.1002/jha2.177  0.012
2021 Huang P, Wang H, Ma D, Zhao Y, Liu X, Su P, Zhang J, Ma S, Pan Z, Shi J, Hou F, Zhang N, Zheng X, Liu N, Zhang L. Serum sodium on admission affects postoperative in-hospital mortality in acute aortic dissection patients. Plos One. 16: e0261168. PMID 34910742 DOI: 10.1371/journal.pone.0261168  0.012
2017 Ma S, Jiang Y, Huang W, Li X, Li S. Role of Transient Receptor Potential Channels in Heart Transplantation: A Potential Novel Therapeutic Target for Cardiac Allograft Vasculopathy. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 23: 2340-2347. PMID 28516902  0.011
1960 MA ST. Observations on 102 cases of pneumonia in infants treated with biomycin Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics. 11: 8-12. PMID 14467689  0.01
2023 Ma Y, Sun WL, Ma SS, Zhao G, Liu Z, Lu Z, Zhang D. LincRNA ZNF529-AS1 inhibits hepatocellular carcinoma via FBXO31 and predicts the prognosis of hepatocellular carcinoma patients. Bmc Bioinformatics. 24: 54. PMID 36803542 DOI: 10.1186/s12859-023-05189-0  0.01
2018 Ma S, Platanias LC. Can early intervention with pharmacotherapy reduce the morbidity and mortality of chronic lymphocytic leukemia? Expert Opinion On Pharmacotherapy. 1-5. PMID 30020813 DOI: 10.1080/14656566.2018.1498844  0.01
2014 Ding R, Wu Z, Qiu G, Wu G, Wang H, Su X, Yin B, Ma S, Qi B. [Selective Laser Sintering-produced porous titanium alloy scaffold for bone tissue engineering]. Zhonghua Yi Xue Za Zhi. 94: 1499-502. PMID 25143173  0.01
2013 Ma SY. The dispute threshold: How the public policy rationale fails to guide the application of federal rule of evidence 408 Cornell Law Review. 98: 997-1022.  0.01
2010 Goolsby C, Peterson L, Ma S, Rosen S. A special supplement issue on MBL: why? Cytometry. Part B, Clinical Cytometry. 78: S2-3. PMID 20839334 DOI: 10.1002/cyto.b.20564  0.01
2005 Ma SM. Kung Fu films in diaspora: Death of The bamboo hero Masculinities and Hong Kong Cinema. 101-118.  0.01
2003 Ma S. Effect of family and society support in rehabilitation of primary stroke Chinese Journal of Clinical Rehabilitation. 7: 1578.  0.01
2002 Ma S, Chisholm RL. Cytoplasmic dynein-associated structures move bidirectionally in vivo. Journal of Cell Science. 115: 1453-60. PMID 11896193  0.01
1998 Ma SY. Clientelism, Foreign Attention, and Chinese Intellectual Autonomy: The Case of Fang Lizhi Modern China. 24: 445-471.  0.01
1993 Ma S. Rapid screening of the Duchenne muscular dystrophy gene deletion by two multiplex PCR Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae. 15: 74-78. PMID 8324844  0.01
1991 Ma S. Evaluation of the effect of health education program of oral hygiene at primary schools Zhonghua Hu Li Za Zhi = Chinese Journal of Nursing. 26: 236-238. PMID 2070478  0.01
1989 Ma SY. Management of traumatic threatened retinal detachment [Chung-Hua Yen K"O Tsa Chih] Chinese Journal of Ophthalmology. 25: 197-199. PMID 2620611  0.01
1987 Ma SF. Ultrasonic biometric measurement of the corneal thickness of 1,008 newborn infants [Chung-Hua Yen K"O Tsa Chih] Chinese Journal of Ophthalmology. 23: 221-222. PMID 3127165  0.01
1983 Ma SY. Extraction of intraocular foreign bodies under microscopy--report of 15 cases [Chung-Hua Yen K"O Tsa Chih] Chinese Journal of Ophthalmology. 19: 68-70. PMID 6409541  0.01
1982 Ma ST. Ultrastructure of lens fibers of the normal rabbit eye [Chung-Hua Yen K"O Tsa Chih] Chinese Journal of Ophthalmology. 18: 153-155. PMID 6813071  0.01
1979 Ma SI. Flame retardation of synthetic fibres by radiation graft polymerization 0.01
Hide low-probability matches.